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In our previous study, we found that H2S offers cardioprotection both in vitro and 
in vivo (Zhu et al., 2007, Chuah et al. 2007). However, the mechanism of how H2S aids 
in the amelioration of myocardial infarction (MI) remains unknown. In our in vitro study, 
we found that H2S and CO have an intricate relationship, working synergistically in the 
mitigation of MI conditions. This is an exciting discovery and may contribute insights in 
the treatment of ischemic diseases. Certainly, more profound and meticulous analysis 
needs to be performed to further substantiate the role of H2S and CO. 
The cell line investigated in this project was rat aortic smooth muscle cells also 
known as vascular smooth muscle cells (VSMC). In our study, sodium hydrogen sulphide 
(NaHS) was utilized as a source of exogenous H2S. Next, for propargylglycine (PAG), it 
was used to effectively inhibit endogenous H2S. The cells were pretreated with 
tricarbonyldichlororuthenium (II) dimer (CORM-2) with an exogenous source of CO. As 
for zinc protoporphyrin-IX (ZnPP), it provided successful repression on heme oxgenase-1 
(HO-1). To simulate MI conditions, we utilized the Modular Incubator Chamber (MIC-
101TM), whereby an effective creation of a steady hypoxic environment with low PO2 was 
created by an air tight seal.  
From the cell viability data, it was shown that cell viability improved with 
pretreatment of NaHS (54.0±0.8%) and CORM-2 (55.0±0.8%) individually, as compared 
to hypoxic control cells. Interestingly, the cell viability improved several folds when both 
NaHS and CORM-2 (91.2±1.6%) were administered. This evidence depicted that NaHS 
and CORM-2 were working synergistically, to ameliorate the hypoxic cellular damage. 
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The cell viability test was indicative of the cellular damage from lactate dehydrogenase 
(LDH) assay. For the LDH levels, the NaHS group (2.23±0.02 fold), CORM-2 group 
(2.20±0.01 fold) were doubled, compared to when both NaHS and CORM-2 (1.35±0.08 
fold) were added. These data were intricately associated with the H2S concentration, 
whereby for the NaHS pretreated group (90.0±1.7μM) and CORM-2 pretreated group 
(68.3±1.7μM) was lower compared to when both NaHS and CORM-2 (145±1.9μM) were 
added. From the H2S assay, it was found that in the NaHS and CORM-2 pretreated group, 
the H2S level was 1.6 fold higher compared to the NaHS pretreated group. Whereas, as 
compared to the CORM-2 group, the NaHS and CORM-2 pretreated group was 2.1 fold 
higher. These data proved that when pretreated with NaHS and CORM-2, the cells had 
several folds improvement in the attenuation of the hypoxic cellular injury as compared 
to when NaHS or CORM-2 was added individually. Furthermore, from cystathionine-
gamma-lyase (CSE) activity and heme oxygenase (HO) activity, it was found that they 
were interrelated with the various treatment groups. As for reverse transcription 
polymerase chain reaction (RT-PCR) on CSE and HO-1 genes, the mRNA level in the 
NaHS and CORM-2 pretreatment group was several folds higher compared to NaHS or 
CORM-2 only pretreated groups. Similarly, from immunohistochemical staining, we 
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Ischemic heart disease (IHD) such as myocardial infarction (MI) is increasing at a 
startling rate in the present era. It is currently the leading cause of death especially in 
developed countries and soon it will become the most common health problem 
worldwide. The high mortality rate of MI is due to the reduction of oxygenated blood to a 
particular part of the heart. Unfortunately, if this lack of oxygenated blood is prolonged, 
it may lead to death to that region of heart tissue, resulting in a heart attack. Another 
plausible reason for high mortality of MI is that, effective medication may not be 
available because of lack of knowledge of the causes and mechanism of MI. 
The pathology of MI is best characterized by lipid accumulation in the coronary 
arteries and fibrous elements. This event is the most imperative contributor to prevalence 
of cardiovascular diseases (Libby, 2002). MI is a multi stage progression characterized by 
early lesions consisting of subendothelial accumulations of ‘foam cells’, which are 
macrophages engorged with cholesterol. 
Interestingly, there is a sequence of events that lead to MI. Firstly, ‘fatty streak’ 
lesions appear in the aorta, and then in the coronary arteries, followed by the cerebral 
arteries (Lusis, 2000). To further worsen the situation, these ‘fibrous lesions’ will develop 
to produce a ‘fibrous cap’ made up of smooth muscle cells (SMCs) and extracellular 
matrix, where a lipid-rich ‘necrotic core’ is found within (Lusis, 2000).  Furthermore, 
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with the complication of calcification and additional deposits, these lesions may impede 
blood flow. However, the most crucial event occurs when there is an acute occlusion via 
the formation of a thrombus, which imminently leads to MI or stroke. 
If this impairment of blood flow towards the heart is prolonged, it triggers another 
process called the ischemic cascade. In this situation, the cardiac cells undergo necrotic 
cell death which implies that there is irreversible cell death. In place, a collagen scar is 
formed. However necrotic cell death is not the sole damage inflicted in MI, another 
consequence is via apoptotic cell death. Krijnen et al. (2002) discovered that apoptosis 
also plays a role in the process of tissue damage following MI. Generally, both kinds of 
cell deaths can lead to irrevocable damage to the heart tissue. 
Although MI has already been established as a silent killer many decades ago, 
there are still escalating cases of this disease. Generally, MI is caused by ischemic 
changes on the myocardium, probably due to stress-related lifestyles, gender (Ivanusa 
and Ivanusa, 2004), stressed-related personality trait (Type A personality), excessive 
intake of alcohol and smoking (Wilson et al., 1998), unhealthy sedentary lifestyles or 
even genetic disposition to certain heart diseases. One vital factor responsible for MI is 
the prevalence of overweight individuals in the modern world where obesity is an 
increasing problem. Adipose tissue is an active endocrine and paracrine organ, releasing 
cytokines and bioactive mediators, such as leptin and adiponectin (Gaal et al., 2006). 
These mediators, at abnormal amounts, may upset the body weight homeostasis as well 
as lipid levels thus increasing the susceptibility to atherosclerosis (Gaal et al., 2006). 
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It is bewildering to realize that despite the wealth of knowledge of the causes and 
prevention of MI, it is still a global problem. One plausible reason may be that the society 
is becoming more affluent. On a global scale, the World Health Organization (WHO) 
estimates that 17 million people die every year from cardiovascular diseases, particularly 
heart attacks and stroke. This is a disturbing phenomenon because it represents 
approximately one-third of all deaths globally. As for the situation in USA, the American 
heart association (AHA) has stated that coronary heart disease caused about 452,300 
deaths in 2004 and is the leading cause of death in America today. In fact, in USA, the 
hospital discharge rate for heart failure has augmented by a bewildering 155 percent over 
the past 20 years (Hellermann et al., 2003). As for situation in the United Kingdom (UK), 
according to The World Health Organization MONICA Project, the cases of MI are 
highest in Belfast and Glasgow compared to the rest of the world. This MONICA project 
endeavors to scrutinize determinants and trends in cardiovascular diseases so as to keep 
the IHD cases in check. 
Heart attack is a global phenomenon which not only affects people in the US and 
UK but Singapore as well, has an escalating incidence of heart attack cases too. This is 
probably due to the more hectic and unhealthy lifestyles of modern people. According to 
the Singapore Myocardial Infarction Registry, it has discovered that women with MI are 
older than men, suggesting that gender differences for the incidence of MI may be age-
specific (Kam et al., 2002). Yet, this trend is not detected for the older age group (Kam et 
al., 2002). 
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Due to the crucial situation of ischemic heart diseases, it is necessary to first be 
aware of the symptoms to allow rapid prognosis. The series of criteria for diagnosis 
includes: firstly, the patient may have suffered ischemic type chest pain lasting for at 
least 20 minutes. The second criterion is determined by observing changes in serial 
electrocardiogram (ECG) tracings. However the most prominent criterion as defined by 
WHO is to monitor the rise and fall of serum cardiac biomarkers namely troponin I, 
creatine kinase and lactate dehydrogenase isozymes which are specific for the heart 
(Gillum et al., 1984). Basically, if any one of the below criteria is fulfilled, one can be 
diagnosed to suffer from MI. 
With the knowledge of the prevalence of MI, the treatment of this disease has also 
evolved to handle the ever increasing cases. Usually the most common drugs to be 
administered are morphine, oxygen, glyceryl trinitrate and aspirin.  
Among the drugs, the most conventional treatment involves the usage of nitrates. 
As reported by Webb et al. (2004), under ischemic conditions, inorganic nitrite (NO2-) 
acts as an endogenous store of nitric oxide (NO•). It was demonstrated that in the 
homogenized myocardium of both rat and human, NO2- is formed from NO• and the 
reaction requires xanthine oxidoreductase (XOR) activity. Other examples of well known 
drugs belonging to the nitrate family are like Isosorbide Mononitrate and Isosorbide 
Dinitrate, which are renowned for dilation of constricted coronary arteries. These drugs 
work mainly via the production of nitric oxide (NO) for cGMP synthesis, which 
ultimately leads to vasodilation to increase blood flow to affected areas. However this 
method does not apply for some individuals, because there is a possibility that smooth 
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muscles vessel wall fails to convert nitrates to NO. If this circumstance occurs, it implies 
that the patient has developed nitrate tolerance (Kośmicki et al., 2000). Thus nitrates may 
not be applicable for all MI patients though NO has been shown in our recent studies to 
be therapeutic effective in MI (Fu et al. 2007). The other category of drugs belongs to the 
beta-blockers like Propranolol, which decreases the heart rate and thus reduces oxygen 
demand. Another group of drugs that are frequently used are the calcium channel 
antagonists that typically decrease the conductivity of cardiac muscles. 
Another interesting method as proposed by Urbanek et al. (2005) in an in vivo 
model was to inject multipotent cardiac stem cells (CSCs) into animals with infarcted 
myocardium. Surprisingly, there was an improvement of the cardiac function. This 
amelioration of cardiac function was seen by the reconstitution of the dead tissue 
compared to the original infarcted region. 
 However there is consistently a need to discover new drugs which are better in the 
current prognosis and treatment of MI. It has been proposed that there are 3 
gasotransmitters which can be exploited, namely hydrogen sulphide (H2S), carbon 
monoxide (CO) and nitric oxide (NO).  
Among them, H2S has been extensively researched in its association with IHD. 
Although H2S has been traditionally viewed as a toxic gas, its advantages has been 
recently been revealed. The mechanism of how H2S works is proposed to be mediated 
mainly by the opening of KATP channels in vascular smooth muscle cells (VSMCs) and 
partially through  K+ conductance in endothelial cells (Zhao et al.,2001). Thus H2S 
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directly increased KATP channel currents and hyperpolarized the membrane which 
brought about the alleviation of ischemic conditions. 
For the biosynthesis of H2S in mammalian cells, there are 2 enzymes involved 
namely: cystathionine-beta-synthetase (CBS), present in the brain (Zhao et al., 2001) or 
cystathionine-gamma-lyase (CSE), present in the heart and VSMCs. It is found that CSE 
is inhibited by propargylglycine (PAG) whereas CBS is inhibited by aminoxyacetic acid 
(Whiteman et al., 2004).  
As for the next well documented gasotransmitter, CO, it has also been 
conventionally viewed as an air pollutant, toxicant and waste. Unfortunately, as an 
environmental toxicant, pathological level of CO can induce acute and chronic health 
hazards (Wu and Wang, 2004). Paradoxically, Wellenius et al. (2004) found that CO 
exposure can in fact decrease the frequency of ventricular arrhythmias. They discovered 
that during the first hour exposure to CO, the ventricular arrhythmias were reduced 
significantly. Thus whether CO is a detrimental or beneficial gasotransmitter, it remains 
for us to find out. 
For the biosynthesis of CO, there are mainly 3 isoforms of enzymes involved: 
heme oxygenase 1(HO-1) which is the inducible form and heme oxygenase-2 (HO-2) 
which is the constitutive form. Heme oxygenase-3 (HO-3) is also a constitutive form of 
HO. Among them, HO-1 and HO-2 are better documented. Furthermore, it is known that 
HO-1 can be inhibited by zinc protoporhyrin IX (ZnPP). 
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In this experiment, rat aortic vascular smooth muscle cells (VSMC) has been 
investigated based on a hypoxic model in vitro.  
1.2 Vascular smooth muscle cells (VSMC) 
Here in our project, rat aortic VSMC was the cell line selected for the exhibition 
of an in vitro model of MI. VSMCs are found in majority of blood vessels walls, 
especially in arteries. Generally, vascular smooth muscles respond to changes in blood 
pressure or blood volume by evidences of contraction or relaxation. More importantly, 
vascular smooth muscles are required for the regulation of normal state of blood vessels.  
With the fact that VSMCs play a critical role, there are other considerable reasons to 
justify the usage of the VSMC cell line. 
 One being that as discovered by Roberts et al. (2005), the atherosclerotic lesion is 
characterized by the neointimal accumulation of smooth muscle cells (SMCs), as well as 
macrophages and lipids. So it is proven that in atherosclerosis, SMCs are present and 
responsible for the model of MI. Furthermore, the source of these SMCs is proposed to 
be from smooth muscle progenitor cells, instead of via migration from the vessel wall 
media (Roberts et al., 2005). 
Evidence is also made known by Lusis (2000), that the fibrous lesions found in 
MI have a ‘fibrous cap’ which consists of the extracellular matrix surrounding a necrotic 
core and VSMCs. As demonstrated, VSMCs are the chosen cells to work with for a more 
comprehensive examination of MI, because more sophisticated lesions are illustrated 
commonly in VSMCs. 
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Ultimately, the choice of VSMCs is practical for an ischemic heart model, 
prompted by the fact that they can be cultured relatively easily with faster proliferation 
rates. Consequently, with a comparatively easy procedure for harvesting of the cells, it 
implies that there is greater ease for subsequent investigation of the role of H2S and CO. 
1.3 Hydrogen sulphide (H2S) 
H2S has been conventionally known for its distinctive pungent odor and thus 
given the name ‘gas of rotten eggs’. The basic properties of H2S are based on its chemical 
and physical properties. It involves the oxidation of H2S, which yields elemental sulfur, 
sulfur oxide (SO2), and sulfates such as sulfuric acid. In fact, H2S can be hydrolyzed to 
hydrosulfide (HS-) and sulfide (S2-) ions in the following equilibrium reaction: H2S Ù H+ 
+ HS- Ù 2H+ + S2- (Wang, 2002). As for the half life of H2S in solution, it is typically 
about a few minutes. Furthermore, as discovered by Wang (2002), H2S is permeable to 
plasma membranes because its solubility in lipophilic solvents is comparatively fivefold 
greater than in water. 
 The effect brought about by H2S as discussed by Moore et al. (2003) and Chen et 
al. (2007) is that it causes relaxation of vascular smooth muscle in both in vitro and in 
vivo models. The relaxation is via the opening of vascular smooth muscle KATP channels. 
Other evidence that supports the role of H2S is that in isolated VSMCs, H2S was found to 
hyperpolarize membrane (Zhang et al., 2001). This was mediated by increasing KATP 
channel currents. Remarkably, it was noted by Zhang et al. (2001) that the H2S 
generating enzyme was identified exclusively in VSMCs, but not in endothelium.  
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 Moreover, it appears that lower concentrations of H2S has distinct vascular 
actions in the rat aorta causeing vasoconstriction and pressor effects. On the other hand, 
at higher concentrations of H2S, it causes vasorelaxation and depressor effects (O’ 
Sullivan, 2006). 
1.4 Endogenous production of hydrogen sulphide (H2S) 
H2S can be produced endogenously, mainly via 2 types of pyridoxal-5’ 
phosphate-dependent enzymes, namely cystathionine-beta-synthase (CBS) and 
cystathionine-gamma-lyase (CSE).  
These 2 enzymes when found in mammalian tissues use L-cysteine as the main 
substrate for the endogenous production of H2S. Surprisingly, both enzymes are not 
necessary for H2S production in some tissues. This implies that the expression of CBS 
and CSE is tissue specific (Wang, 2002). H2S works by exerting a negative feedback 
effect on the activity of these enzymes. This is apparent when elevated H2S level 
inhibited CSE activity and the rate of gluconeogenesis from cysteine (Wang, 2002). 
Other than the conventional methods of production of H2S, it can also be 
produced via phosphogluconate, glycolysis and glutathione as indicated in Figure 1. 
However this process is tightly controlled where the rate of gluconeogenesis from 
cysteine is negatively regulated by H2S. Another less significant endogenous production 
of H2S is via a nonenzymatic pathway. It is done via the reduction of elemental sulfur to 




1.5 Cystathionine-beta-synthase (CBS) and H2S production 
CBS is found to be highly expressed in the hippocampus and cerebellum, in the 
presence of cysteine and pyridoxal-5’-phosphate as shown in Figure 2. This 
substantiation was supported by Abe and Kimura (1996), as they found that the H2S 
production was inhibited by CBS inhibitors like hydroxylamine and aminooxyacetate. On 
the contrary, CBS was triggered by an activator of CBS, S-adenosyl-L-methionine 
(AdoMet). All these results conclude that CBS contributes to endogenous production of 
H2S in the brain. 
 
 
Figure 1: Endogenous nonenzymatic production of H2S. (Wang R., 2002) 
Figure 2: Role of CBS and CSE. (Wang R., 2002) 
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Although higher concentrations of H2S inhibit synaptic responses, physiological 
concentrations of H2S facilitate hippocampal long-term potentiation (LTP). Thus 
endogenous H2S does function as a neuromodulator in the brain (Abe and Kimura, 1996). 
It was also verified that N-methyl-D-aspartate (NMDA) receptors are essential for the 
enhancement of LTP, suggesting a novel neuromodulatory role in vivo (Whiteman et al., 
2004). However in the cases of Alzheimer’s disease (AD) patients, the H2S concentration 
is drastically reduced, whereas the protein nitrations are markedly increased (Eto et al., 
2002). In such cases of neurodegenerative diseases, not only does the level of H2S play a 
crucial role, it may be that H2S directly influences the effect of peroxynitrite mediated 
damage. 
After grasping the basic facts of CBS, it is remarkable to note that other than the 
common precursors like L cysteine and homocysteine, steroid hormones are also 
potential putative modulators for the established CBS functions. For instance: 
testosterone and S-adenosyl-L-methionine (SAM) are CBS activators, which provide a 
slower form of the regulation of H2S production (Eto and Kimura, 2002). This is 
heartening news for neurological diseases which require the continual slow release of 
H2S for treatment. 
1.6 Cystathionine-gamma-lyase (CSE) and H2S production 
As for CSE, it is the main enzyme in the cardiovascular system (Moore et al., 
2003). Although a small amount of CSE mRNA was detected in the brain by PCR 
(Erickson et al., 1990), it was undetectable by Northern blot analysis. CSE appears to be 
the primary H2S producing enzyme in peripheral tissues and vascular tissues. 
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Another intriguing fact is that the amount of CSE in vivo in the rat heart is mainly 
in the following order of the intensity of the expression levels: the highest level of CSE 
mRNA is in the pulmonary artery, followed by aorta, then the tail and the lowest 
concentration is in the mesenteric artery (Zhao et al., 2001). 
Other than being located in heart tissues, mRNA for CSE is expressed in mouse 
pancreas and the pancreas homogenates are able to convert L-cysteine to H2S ex vivo 
(Bhatia et al., 2005). Furthermore, when propargylglycine (PAG) was administered to 
rodents, it exhibited effective inhibition of the liver CSE enzyme activity. In addition, 
CSE is well absorbed and is permeable to biological membranes (Bhatia et al., 2005) 
CSE is also a critical enzyme for the synthesis of glutathione (GSH). In ischemic 
diseases, the depletion of GSH apparently leads to a subsequent increase in CSE gene 
expression (Jain et al, 2004). Another factor that is responsible for CSE activity is the 
presence of pyridoxal 5’-phosphate (PLP). If PLP is depleted, CSE activity is inhibited 
and hence endogenous production of H2S is reduced in the myocardium and plasma, 
consequently leading to ischemic diseases (Kelly et al, 2004).  
1.7 Controversial role of hydrogen sulphide(H2S): the possible toxic effects 
Although H2S has recently been identified as a potential 3rd gasotransmitter, it had 
traditionally been known for its harmful effects. At high levels, it forms a complex bond 
with iron in the mitochondrial cytochrome enzymes. This prevents oxygen from binding 
and this situation is catastrophic because cellular respiration is inhibited. 
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Other routes of toxicity can be via oral ingestion of alkali sulphides, which causes 
nausea, vomiting and epigastric pain. It has been documented that an oral dose of 10g to 
15g sodium sulphide would be fatal to humans. As for toxicity inflicted via inhalation of 
H2S, the respiratory, cardiac and nervous systems are potential targets (Tabacova, 1986). 
The mechanism for toxicity is associated with the deactivation of enzymes through the 
cleavage of their disulphide bridges. Another route of toxicity is due to inactivation of the 
enzymes by binding of sulphide to metal co-factors such as Fe2+, Mg2+ or Cu2+. If that 
happens, vital enzymes such as cytochrome oxidase, alkaline phosphatase and carbonic 
anhydrase can be irreversibly denatured (Teague et al.., 2002). Fortunately, humans have 
an intrinsic intestinal enzymatic detoxification system to handle endogenously produced 
sulphide, thus low amount of H2S is relatively harmless (Teague et al.., 2002). 
1.8 Hydrogen sulphide (H2S) interaction with other gases 
Basically there are 3 well known gasotransmitters, namely NO, CO and H2S. The 
characteristics of gasotransmitters as discussed by Wang (2002) are: firstly, they are 
small molecules of gas, freely permeable to membrane. Secondly, they are endogenously 
and enzymatically generated, in which the reactions are tightly regulated. Thirdly, they 
have specific functions being carried out at physiologically relevant concentrations. 
Finally, they have specific cellular and molecular targets. 
In fact, Wang (2002) has documented that H2S, NO and CO does work 
synergistically to facilitate the induction of hippocampal LTP for memory formation. The 
main difference between these three gases is that production of H2S is via the activation 
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of NMDA receptors. In contrast, NO and CO productions do not require the NMDA 
receptors.  
As for the interaction of H2S and NO, it has been revealed that the production of 
H2S endogenously from rat aortic tissues is enhanced drastically by NO donor treatment 
(Zhao et al., 2001). In addition, the NO donor also augments the CSE expression level in 
VSMCs. Another source of evidence as stated by Hosoki et al. (1997), sodium 
nitroprusside (SNP), a NO donor, was in fact increased with addition of 30μM NaHS. 
However, when aortic tissues were treated with 60μM NaHS, it inhibited the supposedly 
vasorelaxant effect of SNP (Hosoki et al., 1997). All the evidences suggest the possible 
interactions of NO and H2S, however the exact mechanism of how these 2 
gasotransmitters work is still not clearly defined yet. 
Figure 3 is a schematic diagram of the possible interactions of NO and H2S 
(Wang, 2002). In pathway 1, H2S reduces the sensitivity of the cGMP pathway to NO 
(Goodwin et al., 1989). As for pathway 2, H2S reduces NO synthase (NOS) expression 
level. In pathway 3, NO increases CSE expression and thus the production of H2S from 
the precursor L cysteine. In pathway 4, NO increases cysteine uptake and subsequently 
increases H2S production via the CSE activation. In pathway 5, H2S can also inhibit the 





 As for the relationship between CO and H2S, they have been extensively 
investigated individually. However, the interaction between CO and H2S and their role in 
MI is still relatively novel. The results from various research groups provide promising 
insights as to how H2S and CO may interact. 
 H2S can be scavenged by methemoglobin or metallo- or disulfide-containing 
molecules such as oxidized glutathione (Wang, 2002).The interaction of hemoglobin and 
H2S is unique. This is because hemoglobin may be the common “sink” for CO in forming 
carboxyhemoglobin. If filled with a particular gas like CO, the binding of other gases in 
this sink like H2S, would affect the individual availability of each gas (Wang, 2002). 
Thus the effect on the targeted cells would be altered. 
Another plausible explanation for the interaction between H2S and CO is 
investigated by Zhang et al. (2004) in a hypoxic pulmonary hypertension (HPH) model. 
It was found that upon administration of an exogenous source of an inhibitor of H2S, the 
Figure 3: Schematic diagram of the possible interactions of NO and H2S. The solid lines represent 
the stimulatory inputs while the dashed lines represent the inhibitory inputs. (Wang R, 2002) 
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plasma H2S decreased. Interestingly, the plasma CO level, HO-1 protein and mRNA 
levels in pulmonary arteries were decreased too. These results suggested that H2S may 
play a regulatory role in the pathogenesis of HPH through up regulating CO/HO pathway 
(Zhang et al., 2004). 
1.9 Carbon monoxide(CO) 
CO is a colorless, tasteless, and odorless gas. When inhaled, it enters the 
bloodstream and binds to the oxygen on hemoglobin, forming carboxyhemoglobin 
(Kapturczak and Agarwal, 2006). Excessive CO causes CO intoxication and it is fatal, 
thus given the name “a silent killer”. 
 In the body, CO is produced endogenously during cellular metabolism, primarily 
from the degradation of heme by the heme oxygenase (HO) enzymes. There are 3 main 
isoforms: an inducible enzyme HO-1, 2 constitutive forms: HO-2 and HO-3.  
Figure 4  is a schematic diagram of heme metabolism when catalyzed  by HO. 
Firstly, HO forms a complex with NADPH-dependent flavoprotein reductase 
(cytochrome P450 reductase) and biliverdin reductase (a cytosolic enzyme) found on the 
endoplasmic reticulum (Wu and Wang, 2005). With the aid of HO, the porphyrin ring of 
heme is destroyed and oxidized at the alpha-methene bridge, producing equimolar 
amounts of CO, biliverdin and ferrous iron (Wu and Wang, 2005). This pathway requires 
NADPH and O2.  The role of cytochrome P450 reductase is to transfer electrons to the 
HO-heme complex. In general, heme breaks down to form biliverdin and CO. Further 
down the reaction, biliverdin forms a complex with iron and it is then released. Then 
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bilirubin is generated from biliverdin, catalyzed by biliverdin reductase. In addition, 
ferrous iron, generated by heme catabolism, is an oxidant which stimulates ferritin 




The intracellular mechanisms for the actions of CO are still not completely 
understood. However, generally CO binds to the iron of heme proteins and affects several 
intracellular signaling pathways (Kapturczak and Agarwal, 2006). CO has been also 
shown to reduce inflammation and vascular dysfunction (Motterlini et al., 2002). 
Although CO has been traditionally referred to as a toxic gas, it is recently 
investigated for its physiological effects as well as potential therapeutic benefits. 
 
Figure 4: Schematic diagram of heme metabolism catalyzed by heme oxygenase (HO). (Wu L.and 
Wang R., 2005) 
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1.10 Endogenous production of Carbon monoxide(CO) 
CO is produced endogenously via the degradation of heme by the heme 
oxygenase (HO) enzymes. This occurs during cellular metabolism, whereby two main 
isoforms of HO are involved: an inducible enzyme, HO-1 and a constitutive HO-2. On 
the other hand, the biological function of HO-3 is still unclear. It is only known that HO-
3 is a poor heme catalyst and its role may be limited to heme binding and sensing (Wu 
and Wang, 2005). 
CO is produced naturally as a breakdown of hemoglobin. In this reaction, heme is 
a substrate for the HO, which produces CO and biliverdin. The biliverdin is then 
converted to bilirubin by biliverdin reductase. The enzyme biliverdin reductase is found 
in macrophages in the reticuloendothelial system. In the case of CO produced 
endogenously, it may have important physiological roles in the body for instance as a 
neurotransmitter. 
1.11 Carbon monoxide releasing molecules (CORMs) 
Carbon monoxide releasing molecules (CORMs) are transition metal carbonyls 
which are potential CO-releasing molecules (CORMs). As characterized by Motterlini et 
al. (2002), these complexes are compounds containing a heavy metal such as nickel, 
cobalt, or iron in the centre, surrounded by carbonyl groups as coordinated ligands. The 
mechanism of how CORMs work is that certain ligands in a metal complex can promote 
CO dissociation, either sterically or electronically. Another way of dissociation is via 
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photodissociation, whereby due to exposure to light, it leads to subsequent CO production 
(Motterlini et al., 2002). 
 Basically, there are 3 groups of CORMs, namely: CORM-1, CORM-2 and 
CORM-3. As depicted in Figure 5, Motterlini et al. (2005) revealed that manganese and 
ruthenium-containing carbonyl complexes (CORM-1 and CORM-2) are soluble only in 
organic solvents. They can relax blood vessels and alleviate acute hypertension in vivo. 
As for CORM-3, it contains ruthenium as a transition metal and it promotes rapid and 
significant relaxation in isolated vessels, mediated by CO production. CORM-3 is the 
first prototype of a water-soluble carbonyl complex that contains an amino acid glycine 
covalently bound to a ruthenium metal. It has been widely demonstrated that CORM-3 
promotes cardioprotection both in vitro and in vivo models of MI as well as in cardiac 
transplantations (Motterlini et al., 2005). 
 Figure 5: Classes of CORMs and their chemical properties.  It depicts the types of CORMs 
identified, the year of their discovery, and their intrinsic chemical properties. (Motterlini et al., 
2005) 
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Following the finding of the 3 main groups of CORMs, Motterlini and colleagues 
(2005) have also discovered another new group of CORMs which is known as CORM-
A1. It is unique because unlike other CORMs, it does not contain any transition metal 
and it is able to release CO at a slower rate. This is a valuable finding as CORM-A1 is 
more versatile in the treatment of chronic diseases where the continual and slow release 
of CO may be mandatory. Furthermore, it is more representative of the innate function 
and property of HO. The rationale being that in its natural form, HO generates CO 
endogenously from heme in a slow and sustained manner. This property is imperative in 
inflammatory and vascular disease which involves the up regulation of the HO-1 
(Motterlini et al., 2005). 
1.12 Heme oxygenase-1 (HO-1) and CO production 
As discussed above, HO-1 is a rate-limiting enzyme that degrades heme and 
subsequently produces CO, bilirubin, and iron. These products have important 
physiologic effects. For example: bilirubin is a potent antioxidant that can alleviate 
ischemia/reperfusion injury. As for CO, it activates soluble guanylate cyclase and inhibits 
platelet aggregation (Foresti et al., 1997). Furthermore, there is a negative correlation 
between the HO-1 concentration and the occurrence of coronary heart disease (CHD) 
(Chen et al., 2005). 
HO-1 is also a heat shock protein, regulated by various physiological and 
pharmacological factors. Particularly, in skeletal muscle tissue, HO-1 is induced by 
exercise and electrical stimulation in vivo (Vesely et al., 1998). It was discovered by the 
same researchers that substrates like hemin and sodium nitroprusside (SNP) are potent 
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inducers of HO-1, by increasing cellular HO activity in both a time- and concentration-
dependent manner. Furthermore, the increase in the HO-1 mRNA level as well as protein 
expression led to the concurrent changes in HO activity (Vesely et al., 1998). 
Although it is known that HO-1 has an intricate relationship with CO production, 
the physiological importance of HO-1 induction following stress situations is still 
unknown. However it has been hypothesized that the HO-1 expression is a defensive 
mechanism for cells and tissues when they encounter various stress stimuli. This defense 
mechanism is perhaps exerted through the end products of heme metabolism: biliverdin 
and bilirubin, which have antioxidant properties (Foresti et al., 1997). Interestingly, in 
response to stress situations like hypoxia, the expression of HO-1 in rat, bovine, mouse, 
and monkey cells are up regulated but hypoxia represses expression of HO-1 in human 
cells (Wu and Wang, 2005). 
With the knowledge that many HO-1 inducers are pro-oxidant, the route of 
administration and dosage should be cautiously selected. The effectiveness of HO-1 
inducers depends on the half-life of in vivo metabolism of HO-1 inducers (Wu and Wang, 
2005). 
1.13 Heme oxygenase-2 (HO-2) and CO production 
HO-2 is a constitutive form of HO enzyme. Its effects are gaining more attention 
in the recent years. This is because it has been reported that HO-2 produces CO which 
may be a neurotransmitter, with effects similar to that of NO (Verma et al., 1993). 
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The highest expression of HO-2 is in the brain, cerebral vasculature, and testes, 
regulated by steroid hormones. Evidence of high HO-2 expression in the brain, includes 
selected neuronal populations, glia, and cerebral vasculature involved in the regulation of 
cerebral blood flow and neuronal activity (Leffler et al, 2006). As for the exact location 
of HO-2 proteins, it is postulated to be anchored to the endoplasmic reticulum via a 
hydrophobic sequence of amino acids at the carboxyl terminus of the protein (Wagener et 
al., 2003). 
Furthermore, it has been found that HO-1 and HO-2 have amino acid sequence 
similarity of 40%. This may imply that both isoforms have a high likelihood of exhibiting 
the same enzymatic activity. With the same mode of enzyme activity, the molecular 
mechanism responsible for the enzyme activity may be analogous too (Ishikawa et al., 
1994). Although both HO-1 and HO-2 produce CO, HO-1 proves to be more widely 
researched and has a greater role to play in CO production. 
1.14 Controversial role of CO: the possible toxic effects 
While CO administered as a gas at relative low concentrations is cytoprotective, 
however at higher concentrations, CO may lead to hemoglobin saturation, injury and 
tissue hypoxia (Kapturczak and Agarwal, 2006). 
The organs most vulnerable to CO-induced acute hypoxia are the brain and heart, 
due to their high oxygen demand. Generally, human intoxication by CO is influenced by 
the functional status of pulmonary ventilation, also known as the endogenous buffering 
capacity which is the level of carbonmonoxy-hemoglobin A (COHb), and the partial 
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pressures of oxygen and CO. The principle is that elevated CO concentration accelerates 
CO binding to normal adult hemoglobin (HbA), forming COHb. Then, COHb impairs the 
oxygen storage capacity of HbA. Furthermore, the oxygen transportation via COHb is 
also reduced (Wu and Wang, 2005).  
 Larger CO exposures lead to significant toxicity of the central nervous system 
and heart. Following poisoning, long-term sequelae often occur. Generally, toxic levels 
of CO affect the hemoglobin, myoglobin, and mitochondrial cytochrome oxidase. The 
most common treatment for CO poisoning is to administer pure oxygen. Of course 
conventional methods of treatment are constantly being replaced with better and more 
efficient modes of remedy. 
1.15 Background of drug of interest 
There are four drugs that are being investigated namely: sodium hydrogen 
sulphide (NaHS), propargylglycine (PAG), tricarbonyldichlororuthenium (II) dimer 
(CORM-2) and zinc protoporphyrin-IX (ZnPP). 
1.15.1 Sodium hydrogen sulphide (NaHS) 
NaHS is a precursor of H2S, a source of exogenous H2S (Teague et al., 2002). The 
powdered form of NaHS requires deionsed water or saline to dissolve it before 




1.15.2 Propargylglycine (PAG)  
It is widely recognized that CSE is the major H2S forming enzyme in the 
cardiovascular system (Moore et al., 2003). In order to validate the role of CSE, PAG 
was administered to prove that the inhibition of CSE gene could inhibit the production of 
endogenous H2S. 
1.15.3 Tricarbonyldichlororuthenium (II) dimer (CORM-2)  
Tricarbonyldichlororuthenium(II) dimer ([Ru(CO)3Cl2]2 or CORM-2) is a 
precursor of tricarbonylchloro(glycinato)ruthenium(II) ([Ru(CO)3Cl(glycinate)] or 
CORM-3) (Motterlini et al., 2002). It was discovered that upon administration of CORM-
2 from a dose of 0 to 420μmol/L for 3 hours to VSMCs, it did not present any 
cytotoxicity (Motterlini et al., 2002). Furthermore, CORMs provide an easy means to 
control the concentration and CO release rate. 
1.15.4 Zinc protoporphyrin-IX (ZnPP)  
Examples of metalloporphyrins (MPs) include: zinc protoporphyrin IX (ZnPP), 
tin protoporphyrin IX, copper protoporphyrin, zinc deuteroporphyrin IX-3, 4-bis-glycol 
and many other MPs. However, ZnPP is the most powerful HO-1 inducer amongst any 
MPs tested because ZnPP is a potent inducer of the enzyme that it competitively inhibits 
(Yang et al., 2001). ZnPP was dissolved in dimethyl sulfoxide (DMSO) immediately 
before each experiment and subsequently diluted to attain the desired concentration 
(Zhuo et al., 1999). 
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1.16 H2S and ischemic heart disease (IHD) 
With the knowledge of the critical properties of H2S, it is imperative to discover 
the potential utilization of H2S in the treatment of IHD. It has been proven by Wang 
(2002) for in vivo models, that an intravenous bolus of H2S could effectively decrease the 
blood pressure by a significant level of 12-30mmHg. This intriguing information has 
suggested that H2S may be capable of considerable vasorelaxation.  
Other than having a significant impact in lowering blood pressure, it has been 
discovered by Zhao et al. (2001) that at the tissue level, H2S induced in vitro relaxation in 
the rat portal vein and aorta. Furthermore, the relaxation of the rat aortic tissues has been 
suggested to be due to the direct interaction of H2S on VSMCs. With all these affirmative 
results, it has prompted the investigation of the definite role of exogenous H2S as well as 
its mode of mechanism, in the alleviation of IHD in this in vitro study. We propose that 
H2S may work synergistically with CO to exert its effect in the mitigation of MI. 
1.17 CO and ischemic heart disease (IHD) 
With the fact that CO does play an imperative role in the management of IHD, it is 
crucial to investigate how CO exerts its effect. It has been found that CO effects are 
regulated mostly by HO-1. 
In relation to the cardiac distribution of HO-1, it has been largely detected in heart 
vascular wall but not in cardiomyocytes. Interestingly, as discovered by Nishikawa et al. 
(2004), the amount of HO-1 protein in normal myocardium is undetectable by western 
blot. Furthermore, it was HO that offers protection from ischemic injury via the HO/CO 
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pathway involved in ischemic vasodilation present in the coronary microcirculation 
(Nishikawa et al., 2004). In order to ensure that HO-1 protein is detectable, exogenous 
addition of hemin or other pathological stimuli, such as MI and hypoxia could be 
employed (Lakkisto et al., 2002). Another interesting fact established is that in response 
to hypoxia, HO-1 is up regulated through the concurrent activation of iNOS in cardiac 
cells. Thus CO production aids in the regulation of vascular tone (Grilli et al., 2003).  
1.18 H2S and CO interaction in ischemic heart disease (IHD)? 
The interaction between H2S and CO in the cardiovascular research areas is 
relatively novel. One source by Zhang et al. (2004) was that exogenous H2S reduced 
pulmonary arterial pressure whilst the plasma CO level and HO-1 protein and mRNA in 
pulmonary arteries were significantly increased. The results showed that H2S could play a 
regulatory role in the pathogenesis of HPH via up-regulating CO/HO pathway, whereby 
HPH is a process involved in cardiac and pulmonary diseases (Zhang et al., 2004). 
1.19 Purpose of study  
In our previous study, we have already established that H2S attenuated hypoxic 
cellular damage, proven by cell viability test, lactate dehydrogenase (LDH) assay and 
H2S assay as well as to detect CSE gene expression (Zhu et al., 2007). However, the 
mechanism of how H2S functions is still unknown. Thus we propose that these 2 
gasotransmitters: H2S and CO may work synergistically in the amelioration of MI. We 
would like to investigate what is the intrinsic relationship between H2S and CO and the 
role they play in IHD when administered concurrently. 
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Taking into consideration of the high mortality of MI, the aim of this study is to 
discover a better alternative to the existing treatment for MI cases. When administered 
individually, we have proven that H2S is cardioprotective (Zhu et al., 2007). But we 
propose that the mechanism of how H2S works may be via the interaction with another 
gasotransmitter, CO and they may work synergistically to alleviate MI. 
In this in vitro study, sodium hydrogen sulphide (NaHS) has been used as a 
source of production of exogenous H2S. As for propargylglycine (PAG), it inhibits the 
endogenous H2S successfully. As for the exogenous source of CO, 
tricarbonyldichlororuthenium (II) dimer (CORM-2) was administered to the cells. For the 
inhibition of HO-1, zinc protoporphyrin-IX (ZnPP) was utilized. As for the hypoxic 
model deployed in this study, the MI condition was simulated by the Modular Incubator 
Chamber (MIC-101TM). It had an air tight seal which permitted rapid creation of a non-
fluctuating hypoxic environment with low PO2. 
Thus, the aim of this research is to investigate if H2S and CO works 
synergistically in the amelioration of MI via an in vitro model. Furthermore, if these 2 
gasotransmitters have an intricate relationship, the number of folds in amelioration has 
been investigated, compared to hypoxic control. 
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Chapter 2 
Materials and Methods 
2.1  Materials 
2.1.1  Cell culture  
 The cell line was from rat aortic smooth muscle cells also known as vascular 
smooth muscle cells (VSMC). It was purchased from the American Type Culture 
Collection; Manassas, VA (ATCC). 
The cells were cultured in cell medium Dulbecco’s Modified Eagle’s Medium 
(DMEM) from Sigma, supplemented with 50ml of 10% fetal bovine serum (FBS) from 
Invitrogen, with the addition of 2ml of G-418 (Genticin) from Invitrogen.  
To detach the cells, 0.5% Trypsin-EDTA was used. DMSO freezing medium was 
used for cell storage. Both were from Invitrogen. Trypan blue solution from Gibco, 
Invitrogen (CA, USA), was used for cell counting with the hemocytometer 
2.1.2  Drugs 
For the treatment groups involving H2S, sodium hydrogen sulphide (NaHS) and 
propargylglycine (PAG) are from Sigma Aldrich Pte Ltd. NaHS powder was dissolved in 
autoclaved deionised water, whereas PAG was dissolved in sterile-filtered DMSO. As for 
the treatment groups involving CO, tricarbonyldichlororuthenium (II) dimer (CORM-2) 
and zinc protoporphyrin-IX (ZnPP) were from Sigma Aldrich Pte Ltd. CORM-2 was 
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dissolved in autoclaved deionized water whereas ZnPP was dissolved in sterile-filtered 
DMSO. 
 For all the respective drugs, they were all prepared and diluted to the desired 
concentration on the immediate day of application to the cell culture. This is to ensure 
that the drugs are stable when being administered to the cell culture. 
2.2  Methods  
2.2.1  Procedure for cell culture 
 The VSMCs were first seeded into T25 flask. After approximately 90% 
confluence had been achieved, the cells were subsequently transferred to T75 flask. The 
procedure involved was that the cells were detached with 1ml of 0.5% Trypsin-EDTA, 
and then 3ml of DMEM was added to prevent the cells from dying. The cells were then 
subjected to centrifugation at 1000 rpm for 5 minutes at 23°C. After the centrifugation, 
the pellet was re suspended with 1ml of DMEM. The cells are then placed into a T75 
flask and topped up with 14ml of DMEM. After 3 days, approximately 1x 105 cells per 
35mm well, were then ready for seeding into 6 well cell culture plates (NUNC). The cells 
were then pre incubated at 37°C in humidified air enriched with 5% CO2 for 24 hours.  
 After 24 hours, the cells were washed with phosphate buffered saline (PBS). 
Immediately, the medium was changed to serum free DMEM. The purpose of serum free 
DMEM was to deprive the cells of any nutrients required so as to detect the positive 
results achieved by the addition of respective drugs. Subsequently, the drugs were added 
into the respective wells (Table 1). 
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Group number Treatment groups 
1 Normoxic control (NC) 
2 Hypoxic control (HC)  
3 10μmol/L NaHS 
4 10μmol/L NaHS + 50μmol/L CORM-2 
5 10μmol/L NaHS + 10μM ZnPP 
6 50μmol/L CORM-2 
7 50μmol/L CORM-2 + 10μmol/L PAG 
8 10μmol/L PAG + 10μM ZnPP 
9 10μmol/L PAG 
10 10μM ZnPP 
  
 The oxygenated cells in the control group (Group 1) were incubated with serum 
free DMEM at 37°C in humidified air enriched with 5% CO2 for 24 hours. As for the 
cells subjected to hypoxic conditions (group 3 to group 10), after the addition of serum 
free DMEM, appropriate doses of the drugs were applied (Table 1), they are incubated 
for one hour and then subjected to hypoxic conditions. Below shows the morphology of 
VSMCs in normoxic conditions (Figure 6) and hypoxic conditions (Figure 7). The 
morphology of the cells aids in the decision of appropriate drug dosages. 
                                    
  
 
Figure 7: Cell morphology of 
VSMCs in hypoxic conditions. The 
cells are rounded up, not attached to 
the flask and some are floating in the 
medium.
Figure 6: Cell morphology of 
VSMCs in normoxic conditions. 
The cells are spindle shaped, well 
characterized and attached to the 
flask. 
Table 1: Experimental groups.
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 For the selection of the effective doses for the respective drugs, the dose for 
NaHS was chosen to be 10μmol/L NaHS. As for PAG, the dose was 10μmol/L PAG. For 
CORM-2, the dose was 50μmol/L CORM-2. Whereas for ZnPP, the effective dose was 
10μM ZnPP .The reason for the choice of the above doses was based on pilot studies 
(data not shown) from observation of the cell morphology of VSMCs. The cell 
morphology for normoxic control (NC) cells (Figure 6) was that the cells were spindle 
shaped and well defined. The cells when treated with the effective doses also exhibited 
similar morphology as the NC cells. On the contrary, for cells exposed to hypoxic 
conditions (Figure 7), the cells would be rounded up in shape and some cells might be 
floating in the medium. This situation is detected if the chosen drug doses were not 
effective. 
The effective doses for other drugs including CORM-2 and ZnPP were 
investigated too. One factor that was taken into consideration for the effective dose for 
CORM-2, was from Clark et al. (2003), where the dose usage for CORM-3 was from a 
range of 10 to 50μmol/L. Evidence showed that at  50μmol/L CORM-3, cell viability was 
the highest even after exposure to 24 hour hypoxia. Since CORM-2 is a precursor of 
CORM-3 and with our pilot studies (data shown), we have ascertained the effective dose 
for CORM-2 to be 50μmol/L. As for the effective dose of ZnPP, it has already 
established by Yang et al. (2001) to be 10μM ZnPP. 
2.2.2  Simulated hypoxia-induced ischemic model 
The hypoxia-induced ischemic model was achieved by the Modular Incubator 
Chamber (MIC-101TM) (Billups-Rothenberg, Del Mar, CA, USA) as previously described 
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(Namiki et al., 1995). As shown in Figure 8 below, the chamber uses surface type seal 
whereby all parts of the O-ring are compressed uniformly by a stainless steel ring clamp. 
This structure of the Modular Incubator Chamber is such that it guarantees little gas flow 
resistance and uniform infusion of gas. This is attained by having semi spherical top and 
bottom as well as cylindrical walls all around. Furthermore, to ensure that there is no 
leakage via cracks during any point in the experiment, the material utilized for the 




The procedure for the creation of a hypoxic environment is as followed: Firstly, 
the 6 well plates were placed in the chamber. Secondly, attach the flow meter to unit. 
Flush for several minutes with desired gas mixture by opening both the inlet and outlet 
ports. Then close the outlet port, to allow the infusion of the desired gas for 10 minutes to 
ensure a uniform low PO2 environment. Seal the Chamber and place at 37°C in the cell 
incubator. The gas utilized is a gas mixture consisting of 95% nitrogen, 4.5% carbon 
dioxide and 0.5% oxygen. Furthermore, it must be noted that the pressure cannot exceed 
2PSI as it will rupture the chamber under intense pressure. 
Figure 8: Modular Incubator Chamber (MIC-101TM) (Billups-Rothenberg, Del Mar, CA, USA).  
The chamber allows for simulation of hypoxia-induced ischemic model by providing reliable air tight 
seal and fast gas exchange. A non-fluctuating hypoxic environment is easily attained. 
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A variation of 2 hours, 4 hours, 6 hours, 8 hours, 12 hours and 16 hours were 
tested for the appropriate hypoxia duration. The effectiveness of the hypoxia treatment 
was determined by cell viability test and LDH assay. It was decided whereby most of the 
cells were dead, but at the same time the cell death was not too extensive so that the 
drugs could still attenuate cell death. The 16 hour hypoxia treatment (later confirmed to 
be 24 hours) was chosen because from pilot studies, it was indicated that this was the 
optimum time span to achieve hypoxic conditions. This time period was based on cell 
viability results as well as other tests obtained from varying the exposure length in the 
pilot studies (data not shown). 
2.2.3  Viable cell counting 
 To access the cell viability, trypan blue was used for staining the cells. The 
principle is based on the fact that dead cells take up the blue dye whereas live cells do not 
take up the blue dye. Thus the cells should not be left standing for too long when trypan 
blue is added. 
 Firstly, the cells were detached from the T75 flask with 3ml of Trypsin-EDTA 
and in order to prevent cells from dying, 5ml of DMEM was added to the flask. After 
which, 100μl of trypsinised cell suspension and 100μl of trypan blue were thoroughly 
mixed via pippetting. Subsequently, 9μl of the mixture was removed and ready for cell 
counting. Cell counting was carried out with the haemocytometer, whereby a cover slip 
was placed on top of the haemocytometer. With the cover-slip in place, transfer a small 
amount of Trypan Blue-cell suspension mixture to both chambers of the hemocytometer. 
Subsequently, carefully touch the edge of the cover-slip with the pipette tip and allow 
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each chamber to fill up by capillary action. This was done gently, to avoid the 
introduction of bubbles that might interfere with the cell counting. 
 The cells in the four corner squares were counted only. Starting with chamber 1 of 
the hemocytometer, count all the cells in the 1 mm center square and four 1 mm corner 
squares. Then repeat the same procedure for chamber 2. If more than 10% of the cells 
appear clumped, repeat entire procedure by vigorously pipetting the original cell 
suspension and the Trypan Blue-cell suspension mixture. If less than 200 or greater than 
500 cells are observed in the 10 squares, repeat the process by altering to a suitable 
dilution factor. 
Below is the equation for accessing cell viability: 
The cell viability formulation = Number of unstained (living) cells/ Total cells counted 
(stained and unstained cells) x 100%. 
 2.2.4  Lactate Dehydrogenase (LDH) activity to assess cell damage 
 After the hypoxia treatment, LDH assay was being implemented using TOX-7 
LDH based in vitro toxicology assay kit (Sigma, St Louis, MO, USA).This assay is a 
means of measuring either the number of cells via total cytoplasmic LDH or membrane 
integrity via the amount of cytoplasmic LDH that is released by the cells into the 
medium. In this experiment, the latter method was selected, that is measuring the 
cytoplasmic LDH release.  
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 The principle of LDH assay (Figure 9) is based on reduction of NAD with LDH 
as the enzyme involved in the reaction. Accordingly, the formation of the reduced form 
of NAD, that is NADH, is used in the conversion of a tertrazolium dye to a soluble, 
colored fomazan derivative. This derivative is then measured spectophotometrically. In 
this case, cell free aliquots of culture medium are obtained for the LDH assay. The LDH 
activity is correlated with the cell viability and assessment of the extent cellular damage. 
 
                                                      
                             
 
 
Before carrying out the LDH assay, the LDH assay mixture was prepared. Firstly, 
equal amounts of the lactate dehydrogenase assay substrate solution, lactate 
dehydrogenase assay dye solution and lactate dehydrogenase assay enzyme preparation 
(to be added last) were mixed thoroughly. The 6 well plates were then centrifuged at 
250G for 4 minutes. After which, 60μl of cell medium was added into the 96 well plate 
(NUNC). This was followed by the addition of 30μl of the LDH assay mixture into each 
of the well containing the cell medium. Immediately, the 96 well plate was then covered 
with aluminum foil to prevent exposure to light, for a duration of 30 minutes. Finally, to 
stop the chemical reaction, one tenth of the total volume in each well (9μl) of 1N 
hydrochloric acid was added into each well. Finally, to assess the cell damage, the 96 
                                           LDH                                Tetrazolium dye 
                          NAD                       NADH 
 
                                                                                   Colored formazan derivative 
Figure 9: The LDH based in vitro toxicology assay kit (Sigma). The conversion of NAD to NADH 
via LDH released from hypoxic cells. NADH was then used in the conversion of the tetrazolium dye to 
a colored formazan derivative for spectrophotometric measurement. 
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well plate was then placed into the SUNRISE Absorbance Microplate Reader (Tecan), 
with a absorbance of 490nm and a background absorbance of 690nm. 
 After the results were obtained, the LDH levels measured from each of the 
treatment groups (Group 3 to 10) were then compared with respect to the baseline LDH 
level in the control group (Group 1). As for the prediction of the protective effects of the 
different treatments, the LDH level for each treatment group was expressed with respect 
to the LDH level in the hypoxia group (Group 2). 
2.2.5  Hydrogen sulphide (H2S) assay 
To assess the amount of H2S produced in the cell medium for each treatment 
group, H2S assay was implemented. The principle of how this assay works is that H2S is 
chemi-adsorbed by zinc acetate and subsequently transformed into stable zinc sulfide. 
After which, the sulfide is recovered via extraction with water. In contact with an 
oxidizing agent such as ferric chloride (FeCl3) in a strongly acidic solution, it reacts with 
the N, N-dimethyl-p-phenylendiammonium (NNDPD) ion to yield methylene blue. This 
explains the blue color obtained after the reaction. 
Before proceeding to measure the actual amount of H2S produced, a standard 
must be established. Firstly, 0.05g of 30mM Iron Chloride (FeCl3) was dissolved in 1.2M 
of hydrochloric acid (HCl). Then 0.04g of 20mM of N, N-dimethyl-p-
phenylenediaminutese dihydrochloride (NNDPD) was dissolved in 7.2M of HCl. Lastly, 
to prepare H2S solution, appropriate amount of NaHS was dissolved in deionised water. 
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Then 1M of H2S solution (standard 11) was prepared from a 3M H2S solution via a three 
times dilution, to ensure that the H2S solution was stable. 
From standard 11, 300μl of H2S solution was transferred to standard 10, to 
achieve a concentration of 100mM. The following standards were achieved via the 
appropriate dilutions as seen from Table 2. Below were the steps involved in preparation 
of the H2S standard. 
Standard Standard to 
be diluted 
Volume of 







11 NA NA NA 1M 
10 11 300 2700 100mM 
9 10 300 2700 10mM 
8 9 300 2700 1mM 
7 8 750 2250 200μM 
6 7 1200 1800 100μM 
5 6 1500 1500 50μM 
4 5 1500 1500 25μM 
3 4 1500 1500 12.5μM 
2 3 1500 1500 6.25μM 
1 2 1500 1500 3.125μM 
0 NA NA NA 0 
 
After the preparation of standards, the following were added into each of the 8 
eppendorf tubes: 250μl of 1% zinc acetate, 500μl of standard, 133μl of NNDPD and 
133μl of FeCl3.  These 8 treatments were done in duplicates. After the addition of each of 
the respective chemicals, the tubes were mixed thoroughly. The amount of standard to be 
added to each of the eppendorf tubes were as followed: For eppendorf tube 1, 500μl of 
water was added; for eppendorf tube 2, 500μl of standard 1 was added; for eppendorf 
tube 3, 500μl of standard 2 was added. The standards (from standard 3 to 7) to be added 
Table 2: H2S standard preparation.
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would be subsequently be in this sequence. Shake the solutions and incubate them for 10 
minutes at room temperature. After 10 minutes had elapsed, 250μl of 10% 
Trichloroacetic acid (TCA) was added to each of the eppendorf tubes to deproteinate the 
mixture. Subsequently, 300μl of the mixture was transferred into a 96 well plate 
(NUNC), ready for reading via SUNRISE Absorbance Microplate Reader (Tecan), at an 
absorbance of 670nm. After which a standard curve was constructed, where the ideal R 
value was more than 0.995. 
 With the aim of finding out the amount of H2S produced for respective treatment 
groups, the same steps were repeated. The mixture consisted of 250μl of 1% zinc acetate, 
425μl of deionised water, 75μl of standard, 133μl of NNDPD and 133μl of FeCl3. After 
incubation of 10 minutes, 10% TCA was added. Then an extra step of centrifuging the 
samples at 3000rpm for 5 minutes was executed. Similarly, 300μl of supernatant was 
transferred to the 96 well plate (NUNC), to be placed into the SUNRISE Absorbance 
Microplate Reader (Tecan), at an absorbance of 670nm. 
2.2.6 Cystathionine-gamma-lyase (CSE) activity assay 
 To determine the CSE enzyme activity, the CSE assay was implemented. 
Basically, there were various components like pyridoxal phosphate, cysteine, NNDPD 
and FeCl3 to be freshly prepared. For each treatment group, there were 2 eppendorf tubes 
involved: tube A and B.  
 The preparatory work involved was to add 2ml of 100mM phosphate buffer into 
each 6 well plate and the cells were detached with a cell scrapper. After which the 
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supernatant was extracted and centrifuged at 24 000G for 2 minutes at 4°C. Then with the 
supernatant, the following procedure was carried out. 
 Firstly, 430µl of supernatant was transferred into eppendorf tube A, which was 
referred to as 30 minute tube. Duplicates of tube A were prepared. After which, 30µl 
saline; followed by 20µl of pyridoxal phosphate; followed by 20µl of cysteine were 
added. These 2 tubes A were then incubated at 37°C for 30 minutes in the water bath. 
During this time, 430µl of supernatant was transferred into a new eppendorf tube B, 
which was referred as the 0 minute tube. This tube acted as a negative control. 
Subsequently, 250µl of 10% TCA was added. As for the source of positive control, an 
eppendorf tube C was needed. To tube C, 430µl of phosphate buffer and subsequently 
250µl TCA were added. For the following steps, they were performed for both tubes B 
and C, which was to add 30µl of saline, 20µl of pyridoxal phosphate, 20µl of cysteine 
and 250µl of 1% zinc acetate in sequence to tubes B and C. Then both tubes B and C 
were centrifuged at 24 000G for 3 minutes at 4°C.  After the centrifugation, 133µl of 
NNDPD was added, followed by 133µl of FeCl3. Subsequently, centrifugation was 
carried out again at 24 000G for 3 minutes at 4°C. Finally, 300µl of supernatant was 
pippetted into microplate and read for absorbance at 670nm with SUNRISE Absorbance 
Microplate Reader (Tecan). 
 After 30 minutes had elapsed, tube A was removed from the water bath. The 
procedure involved was to add 250µl of 1% zinc acetate and 250µl of 10% TCA using a 
needle. The purpose of the needle was to ensure that the reaction was kept constant. Tube 
A was centrifuged at 24 000G for 3 minutes at 4°C, followed by addition 133µl of 
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NNDPD and 133µl of FeCl3. Similarly, 300µl of supernatant was pippetted into 
microplate and read for absorbance at 670nm with SUNRISE Absorbance Microplate 
Reader (Tecan). 
 After the assay had been carried out, H2S assay was implemented. The purpose 
was to find out the amount of H2S produced for respective groups. CSE activity assay is 
expressed in terms of (μmol/ml)/g, where it is based on the amount of H2S (μmol/ml) 
produced per amount of protein produced (g). 
  As for the amount of protein yielded in each treatment group, it was determined 
by Quick Start Bradford protein assay (Bio-Rad, USA). The Bradford assay is a protein 
determination method that involved the binding of Coomassie Brilliant Blue G-250 dye 
to proteins. Firstly, protein standards using bovine serum albumin (BSA) from 0-2mg/ml 
were plotted. Then for the samples, 5µl was added to 250µl of Bradford Bio-Rad dye into 
a microplate. Then the samples were incubated for 10 minutes and absorbance was 
measured at 595nm. 
2.2.7 Heme oxygenase (HO) activity assay 
HO activity in VSMCs was measured via bilirubin generation. The cells were 
grown to confluence in 6 well plates. Then 100μl of 100mM potassium phosphate buffer 
was added into each well and subsequently detached using a cell scrapper. The cell 
supernatant was then centrifuged at 12000G for 10 minutes at 4°C, after which the clear 
supernatant was then transferred to fresh tubes. The protein content was then determined 
via dye-binding assay (Bio-Rad). After the total protein content was ascertained, the 
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following constituents like rat liver cytosol, NADP, glucose-6-phosphate, and glucose-6-
phosphate dehydrogenase and hemin were calculated accordingly to achieve the desired 
concentrations.  
Subsequently, the supernatant was added to a reaction mixture (1.2ml) containing 
rat liver cytosol (2mg), NADP (0.8mM), glucose-6-phosphate (1mM), and glucose-6-
phosphate dehydrogenase (0.2unit). Finally, 20μl of 2.5mM hemin was added as the 
substrate. The mixtures were then aerobically incubated for 10 minutes at 37°C in the 
dark. To terminate the reaction, the tubes were placed on ice.  As for the negative control 
group, NADP, glucose-6-phosphate, and glucose-6-phosphate dehydrogenase and hemin 
were added. Then chloroform was added to quench the reaction. Finally, the source of 
enzyme provided by the rat liver cytosol was added. Thus the readings for all treatment 
groups were subtracted from this negative control.  Then the amount of bilirubin formed 
was measured with a SUNRISE Absorbance Microplate Reader (Tecan) at an absorbance 
of 464-530 nm. As for the extinction coefficient of bilirubin, it is 40 mM-1.cm-1. Finally, 
HO activity was expressed as pmol of bilirubin formed per mg of cell protein in 60 
minutes. The protein content was then determined by a dye-binding assay (Bio-Rad). 
2.2.8  Total RNA isolation 
The cells were washed with 2ml of PBS and 1ml of TRIZOL Reagent (Invitrogen, 
CA, USA) was added into each of the 35mm diameter well. Then, with a cell scraper, the 
cells were being detached via a circular scraping motion, and transferred into a fresh tube. 
The cell lysate was then incubated at room temperature for 5 minutes to allow the 
nucleoprotein complexes to dissociate completely. 
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 Next for phase separation, 0.2ml of chloroform was added to the cell lysate 
followed by shaking the tubes for 15 seconds for the formation of a homogenous mixture. 
The tubes were then incubated at room temperature for 2 minutes. After which, the tubes 
were centrifuged at 12 500G for 5 minutes at 4°C. RNA should be found exclusively in 
the upper aqueous layer which was colorless. 
 After the phase separation, RNA precipitation was carried out. Firstly, the 
aqueous phase was transferred into a fresh tube and 0.5ml of isopropanol per 1ml of 
TRIZOL was added. This was to ensure that RNA would precipitate from the aqueous 
phase. Next, the samples were incubated at room temperature for 10 minutes. After 10 
minutes, the tubes were centrifuged at 12 000G for 10 minutes at 4°C. Finally, there 
should be the formation of RNA pellet at the bottom of the tubes. 
 The following step was the RNA wash step. The supernatant was removed and 
washed with 1ml of 75% ethanol per 1ml of TRIZOL reagent. The sample was then 
mixed via vortexing. The samples were once again centrifuged at 7500G for 5 minutes at 
4°C. 
 Finally, the RNA pellet was air dried at room temperature to remove traces of 
ethanol. However, extra caution was required to prevent complete dryness of the RNA. 
Then, the RNA was being dissolved in 30μl of DEPC (diethyl pyrocarbonate) treated 
double-distilled water via pippeting the solution several times. After that, the samples 
were then being incubated for 10 minutes with the heat block at 55°C to 60°C. 
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2.2.9 Quantification of RNA 
The aim of measuring the RNA with the spectrophotometer was to ensure the 
degree of purity of the RNA and also to determine the amount of RNA to be used for the 
subsequent reverse transcription polymerase chain reaction (RT-PCR). 
Firstly, to perform a 100 times dilution of the RNA, 1μl of RNA was mixed with 
99μl of RNase-free water, whereby the absorbance were read off at wavelengths of 
260nm(A260)and 280nm(A280). The A260 for the reading extinction coefficient of 1 unit 
(O.D) is equivalent to 40 µg/ml RNA. If the reading was more than 1, then the samples 
should be diluted 100 times with DEPC water. The aim was to achieve the final working 
RNA concentration of 1µg/µl. As for the assessment of the degree of purity of RNA, the 
absorbance at wavelength 260nm and 280nm were being recorded. Then the ratio of 
A260/A280 ratio was calculated, whereby the ratio preferably was between 1.5 and 2.0.  
 Subsequently, to find out the concentration of RNA to be used, the following 
calculation was done: Absorbance x A260 for the reading extinction coefficient of 1 unit 
(O.D) x dilution factor. In this case, the dilution factor applies only if the appropriate 
dilution was implemented. 
2.2.10  Reverse transcription polymerase chain reaction (RT-PCR) 
 Total RNA was reverse transcribed and subsequently amplified for the respective 
gene of interest. The RT-PCR reaction was done using the QIAGEN OneStep RT-PCR 
kit (Qiagen, USA). The following pre-PCR thermal conditions were used for all the 
RNA, consisting of reverse transcription at 50°C for 30 minutes, followed by activation 
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of the HotStart DNA polymerase at 95°C for 15 minutes. Before carrying out the RT-
PCR, a master mix was prepared. Table 3 shows the composition of the master mix. 
Reagents                                                                   Volume to be added  
QIAGEN OneStep RT-PCR 5x buffer                       2.5µl 
 
QIAGEN OneStep RT-PCR dNTP mix                     0.5µl 
  
Anti sense primer                                                       0.75µl 
 
Sense primer                                                               0.75µl 
 
QIAGEN OneStep RT-PCR Enzyme Mix                 0.5µl 
 
RNase-free water                                                        Vary according to RNA volume 
 
RNA                                                                            Vary according to quantification 
Total volume of mixture                                             12.5µl 
 
 
The master mix for the RT- PCR consisted of the following as stated above. The 
QIAGEN OneStep RT-PCR kit consisted of 5 x buffer, QIAGEN OneStep RT-PCR 
dNTP mix which contained 10mM of each dNTP, QIAGEN OneStep RT-PCR Enzyme 
Mix which consisted of two high-affinity reverse transcriptases namely Omniscript and 
Sensiscript transcriptases as well as a HotStarTaq DNA polymerase, and lastly the 
RNase-free water. In this case, GAPDH was used as the house keeping gene. Thus equal 
amounts (0.75µl) of each sense and antisense GAPDH primers were utilized respectively. 
The purpose of the house keeping gene was to ensure there was standardization whilst 
implementing gel electrophoresis. The mRNA for the constitutive GAPDH was utilized 
as the reference cellular transcript, to ensure that the GAPDH amplification products 
were expressed at equal levels in all the samples of cell lysates.  
Table 3: RT-PCR constituents.
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 For GAPDH gene, the denaturation temperature was 94°C for 30 seconds, the 
annealing temperature was 55°C for 30 seconds and the extension temperature 72°C for 
30 seconds, continued with a final 10 minutes extension at 72°C after the thermal 
cycling. The number of cycles was between 25 to 30 cycles. On the other hand, for the 
CSE gene, the denaturation temperature was 94°C for 30 seconds, the annealing 
temperature was 57.5°C for 45 seconds and the extension temperature was 72°C for 30 
seconds, continued with a final 10 minutes extension at 72°C after the thermal cycling. 
As for the number of cycles, it was 26 cycles. Finally for HO-1 gene, the samples were 
kept at 94°C for 15 minutes and then subjected to thermocycling. The denaturation 
temperature was 94°C for 1 minute, the annealing temperature was at 57°C for 1 minute, 
and the extension temperature was 72°C for 1 minute, with a final 5 minutes extension at 
72°C. The number of cycles was 30 cycles. The primer sequences used for the cDNAs of 
GAPDH, CSE and HO-1 genes are listed in Table 4.  
Gene 
/ (Accession number)                        Sense/ Antisense                                       Size (bp)                          
 
GAPDH                           Sense 5' CATGGTCTACATGTTCCAGT-3',                  349bp 
                                        Antisence 5'-GGCTAAGCAGTTGGTGGTGC-3'       
CSE (AB_052882)          Sense 5’ CAT GGA TGA AGT GTA TGG AGG C 3’    445bp       
                                        Antisense 5’ CGG CAG CAG AGG TAA CAA TCG 3’ 
HO-1 (NM_012580.2)    Sense 5’ CAC CAG CCA CAC AGC ACT AC 3’ 
                                        Antisense 5’ CACCCA CCC CTC AAA AGA CA 3’      1043bp 
 
2.2.11  Agarose gel electrophoresis  
The PCR products were electrophoresed on 1.5% agarose gel (Bio-Rad). 1.5µl of 
ethidium bromide (EtBr) was added, so that the bands were fluorescently labeled for the 
Table 4: Oligonucleotide sequences of primers used for RT-PCR. 
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easy manipulation of results. 10µl of the PCR products were then removed from each of 
the reaction tubes and mixed thoroughly with 2µl of 5x blue/orange loading dye 
(Promega, USA). 
Before loading on the samples, 10µl of 1 kbp DNA ladder (Promega, USA) was 
mixed well with 2µl of blue/orange loading dye. Finally, the DNA ladder as well as the 
samples was all loaded into the wells. In order to run the gel, the MultiGenius 
Bioimaging system (Syngene, UK) was utilized and set to a constant voltage of 125volts 
and for 45 minutes.  
After which, the gel was then imaged by the gel doc machine (Bio-Rad). The gel 
was viewed under the option of ‘UV Transilluminutesation’. The software program used 
for this machine was ‘Quantity One’. In order to quantify the amount of mRNA, the band 
intensity was then analyzed via the ChemiDoc XRS (Bio-Rad) under the option of 
‘Volume INT*mm2’.To normalize for differences in total RNA added into the respective 
tubes, the constitutively expressed GAPDH was selected as a reference for the total 
cellular RNA loaded respectively for each sample. Subsequently, the amount of RNA 
used for each reaction was then adjusted accordingly to ensure the house keeping gene 
band intensities were constant, with a permissible difference of ±20%. Finally, the results 
were then expressed relative to the equivalent intensity of the housekeeping gene, 




2.2.12 Sample preparation for Immunostaining 
 To prepare for immunostaining of cells, cover slips were placed into the 6-well 
plates with autoclaved tweezers. The cells were seeded onto the cover slips and 
confluence was attained after 24 hours. After which, the cells were treated with 
appropriate drug dosages similar to the addition of drugs as before. The cells were fixed 
with 4% paraformaldehyde for 25 minutes at 4°C. Subsequent steps for immunostaining 
were carried out in the wells. 
2.2.13 Antibody staining 
The purpose of immunostaining was that it permitted the visualization of antigens 
via the sequential application of a specific primary antibody to the antigen, with 
subsequent binding of secondary antibody to the primary antibody, as well as formation 
of an enzyme complex and a chromogenic substrate with interposed washing steps. 
Following this chromogenic enzymatic activation, a visible reaction product was detected 
at the antigen site.  
A ready to use UltraVision Detection System Anti-Polyvalent, HRP/DAB kit 
(Lab Vision Corporation, CA, USA) was purchased for the antibody staining. The cover 
slips in the wells were first washed with 0.2% 1x phosphate buffered saline-Triton X 
(0.2% PBS-Tx) for five minutes. Then the cover slips were incubated with hydrogen 
peroxide block for 5 minutes at room temperature. The role of hydrogen peroxide was to 
block endogenous peroxidase activity which could mask any positive staining of the 
specific antigens. After blocking, the cover slips were washed twice in 0.2% PBS-Tx, 
five minutes each time. Subsequently, Ultra V Block was used to incubate the cover slips 
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for 5 minutes. This step was required for suppressing any possible nonspecific 
background staining. Then the cover slips were rinsed in 0.2% PBS-Tx. After which, 
primary antibody was added. The following primary antibodies were used: polyclonal 
rabbit anti-CSE antibody (manufactured from our laboratory) and polyclonal rabbit anti-
HO-1 antibody (sc-10789, Santa Cruz, CA, USA). The polyclonal rabbit anti-CSE 
antibody was used for incubation of the specimens for 2 hours. Whereas the polyclonal 
rabbit anti-HO-1 antibody was used for incubation of the specimens for 3 hours. The 
dilutions of the antibody were done according to manufacturer’s instruction and the 
antibodies were diluted with 0.2% PBS-Tx. Extra caution was needed to prevent the 
cover slips from drying up and this is done by continual addition of the primary 
antibodies.  
After incubation with the primary antibody for the optimized times, the cover 
slips were washed with 1x phosphate buffered saline (1x PBS) for 4 times, 5 minutes 
each. After the successful incubation of the primary antibody, the specimens were 
incubated with Biotinylated Goat Anti-Polyvalent for 2 hours. Similarly, continual 
addition of the secondary antibody was needed to prevent complete drying up of the 
slides. After the optimal incubation duration with secondary antibody, the specimens 
were then washed with 1x PBS 4 times, 5 minutes each. 
Then, the cover slips were incubated with streptavidin peroxidase for 10 minutes, 
which conjugated with biotin found on the secondary antibody. Subsequently, the 
specimens were washed in 1x PBS 4 times, 5 minutes each. After which, 3, 3’ 
diaminutesobenzidine tetrahydrochloride (DAB) working solution was used for detection 
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of specific antibody, secondary antibody and streptavidin-enzyme complex. This 
colorimetric detection was performed with a working mixture of one drop of liquid DAB 
in 1ml of chromogen solution. The slides were rinsed immediately in 1x PBS for 4 times 
once a brown tinge was detected. 
2.2.14 Counterstain -- Hematoxylin Staining 
The purpose of the hematoxylin staining was that it stained nuclei blue via the 
binding of a mordant dye complex to nucleic acids and histone proteins of the 
heterochromatin. This allows for the detailed observation of the morphology of the 
specimens. 
After the brown tinge was detected, hematoxylin was added to the wells for 
attachment to the cover slips. This is an essential step for counter staining. To prevent 
strong background staining, the specimens were washed immediately with tap water to 
remove traces of hematoxylin. After counter staining, the next step involved was 
dehydration. This is implemented by addition of gradual increasing concentrations of 
ethanol. Firstly, with 70% ethanol for one minute, then 80% ethanol for one minute, then 
100% ethanol for 2 times, one minute each. Lastly, addition of xylene 2 times, one 
minute each.  
2.2.15 Mounting of Slides 
The last step is indispensable for the permanent storage of specimens. The 
specimens were mounted by a drop of mounting medium Permount (Fisher Scientific 
International, PA, USA). Subsequently the specimens were then mounted to polysine-
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coated slides. After the slides were dried overnight in the hood, they were viewed and 
photographed using a fluorescent Leica® microscope (Leica Microsystems, IL, USA). 
2.2.16 Statistical Analysis 
All relevant data collected were expressed as means ± SEM. As for the statistical 
analysis, it was achieved using the unpaired Students t test. Finally, a difference with p < 








3.1 Testing of dose for administration of CORM-2 
 Since CORM-2 is a relatively new drug which has not been established in the 
VSMC cell line, thus the appropriate dosage has to been ascertained. The doses to be 
tested were 10μmol/L CORM-2, 25μmol/L CORM-2 and 50μmol/L CORM-2. An 
additional group of 10μmol/L CORM-2 with 10μmol/L NaHS was used to investigate if 
CORM-2 and NaHS have an intricate relationship. The following tests were 
implemented: cell viability test, LDH assay, H2S assay and RT-PCR. 
3.1.1 Cell Viability test via Trypan blue exclusion (Testing of dose for CORM-2) 
In order to access the appropriate dosage of CORM-2, cell viability test was being 
implemented for different dosages of CORM-2. The cells were being incubated in serum 
free DMEM for one hour and then followed by 16 hours of hypoxia. Our stable hypoxic 
condition with low PO2 was achieved by the Modular Incubator Chamber (MIC-101TM). 
The results in Figure 10 show that in the HC, the cell viability decreased from 
95±0.6% to 71±0.9%. For 10μmol/L CORM-2, 25μmol/L CORM-2 and 50μmol/L 
CORM-2, the cell viability were 40±0.19%, 80±1.3% and 92±0.8% respectively. Thus 
the highest cell viability was correlated to optimal dosage of CORM 2 which was 
50μmol/L CORM-2. As for when both 10μmol/L CORM-2 and 10μmol/L NaHS were 





3.1.2 Assessment of cell damage via Lactate Dehydrogenase Assay (LDH) (Testing 
of dose for CORM-2) 
 To confirm the credibility of the cell viability test, LDH assay was performed for 
the assessment of cyto-toxicity. The rationale for this assay is that LDH activity 
correlates to the cell viability as well as an assessment of extent of cellular damage. The 
respective LDH levels in culture medium after hypoxia treatment were expressed as 
percentage relative to NC. As for the measurement of the degree of hypoxic cellular 
damage, the LDH levels for each of the treatment groups were expressed as a percentage 
compared with the NC. Statistical tests were then carried out with respect to the HC. 
From Figure 11, it is apparent that the LDH level for HC was much higher, which 
was 1.89±0.07 fold higher than NC. For the different dosages of CORM-2, for 10μmol/L 
CORM-2, 25μmol/L CORM-2 and 50μmol/L CORM-2, the LDH levels were 1.58±0.02 
Figure 10: Cell viability test for different dosages of CORM-2. NC, normoxic control; HC, hypoxic 
control. All the drug treatments were carried out under hypoxic conditions. The data shown are mean ± 
SD (n=6).* indicates p<0.05 compared to HC.  
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fold, 1.31±0.02 fold and 1.01±0.07 fold respectively compared to NC. Thus the least 
cellular damage was detected when 50μmol/L CORM-2 was administered. As for when 
both 10μmol/L CORM-2 with 10μmol/L NaHS were added, the LDH level was 
1.27±0.05 fold, which indicated significantly lower cellular damage compared to HC 
group. From the cell viability and LDH level, it implied that the 50μmol/L CORM-2 was 














Figure 11: Relative lactate dehydrogenase (LDH) production for different dosages of CORM-2. 
NC, normoxic control; HC, hypoxic control. The drug treatments were all carried out under hypoxic 
conditions. Levels of LDH for each treatment group produced were expressed as a percentage of that 
induced by NC. Statistical test was performed for all treatment groups with respect to HC. The data 
shown are mean ± SD (n=6).* indicates p<0.05 compared to HC. 
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3.1.3 To determine amount of hydrogen sulphide (H2S) produced via H2S assay 
(Testing of dose for CORM-2) 
To assess the amount of H2S produced in the cell medium for each treatment 
group, H2S assay was implemented. For NC, the concentration of H2S produced was 
82.5±1.5μM (Figure 12). As for HC, the H2S concentration was 80.2±0.9μM, which was 
lower than NC. For the different dosages of CORM-2, that were 10μmol/L CORM-2, 
25μmol/L CORM-2 and 50μmol/L CORM-2, the H2S concentrations were 93.1±2.0μM, 
93.4±2.6μM and 108.9±2.0μM respectively. Thus the highest concentration of H2S was 
detected when 50μmol/L CORM-2 was administered. As for when both 10μmol/L 
CORM-2 with 10μmol/L NaHS were added, the H2S concentration was 76.8±3.5μM, 
which was lower than the HC group. 
 
 
Figure 12: Concentration of H2S produced by each treatment group. NC, normoxic control; HC, 
hypoxic control.All the drug treatment groups were carried out under hypoxic conditions. The data 
shown are mean ± SD (n=6).* indicates p<0.05 compared to HC.  
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3.1.4 Reverse transcription polymerase chain reaction (RT-PCR) (Testing of dose 
for CORM-2) 
To certify that the chosen dosage was reliable from all the above experiments, 
RT-PCR was carried out. This was done to investigate if the different dosages would up-
regulate or down-regulate the CSE gene expression. The RT-PCR experiments were 
repeated three times independently for each data point, to evaluate the credibility of the 
data. Below in Figure 13, the standardization for the different dosages with the house 
keeping gene GAPDH was depicted. After the standardization was performed, running of 







 The relative CSE mRNA level for the NC was defined as 100%. As depicted in 
Figure 15, the CSE mRNA level for the HC was 45.0±3.3%. For the different dosages of 
CORM-2, for 10μmol/L CORM-2, 25μmol/L CORM-2 and 50μmol/L CORM-2, the CSE 
Figure 13: Standardization of GAPDH.  The drug 
treatments were all performed under hypoxic 
conditions. This was to facilitate the normalization of 
mRNA levels of CSE to the amount of GAPDH in each 
respective group. The size of the PCR product was 
349bp. 
Figure 14: Gene expression for CSE. The drug 
treatments were all performed under hypoxic conditions. 
mRNA levels of CSE were normalized to the amount of 
GAPDH for each treatment group respectively. 
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mRNA levels were 38.9±1.7%, 38.5.4±0.7% and 36.2.9±3.2% respectively. On the other 
hand, when both 10μmol/L CORM-2 with 10μmol/L NaHS were added, the CSE mRNA 









3.2 Cell Viability test via Trypan blue exclusion for 16 hours hypoxia treatment 
After the determination of the appropriate doses for NaHS, PAG, ZnPP and 
CORM-2 (data shown above), the appropriate hypoxia treatment duration had to be 
ascertained. From pilot studies (data not shown), it was decided that16 hours hypoxia 
treatment was adequate for the implementation of experiments involving VSMCs. 
Figure 15: Relative CSE mRNA level (%NC). NC, normoxic control; HC, hypoxic control. 
Quantitative RT-PCR for CSE was performed. 10μl of PCR products from various treatment were 
loaded onto 1.5% agarose gel, stained with ethidium bromide. The sizes of the PCR products for 
GADPH and CSE are 349bp and 445bp respectively. In this case, the mRNA levels of CSE are 
normalized to the amount of GAPDH for the different treatment groups. The data given are mean ± SD 
(n=6).* indicates p<0.05 compared to NC. RT- PCR was repeated three times independently for each 
data point. 
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Firstly, cell viability was carried out with the 16 hour hypoxia treatment for all the 
experimental groups with the appropriate dosages of drugs. Similarly, the cells were 
placed in the Modular Incubator Chamber (MIC-101TM), with a non fluctuating hypoxic 
environment with low PO2, simulated to be similar to MI conditions. 
The results in Figure 16 show that in the HC, the cell viability decreased from 
94.5±0.6% to 70.7± 0.9%. After the addition of NaHS, the cell viability increased to 
87.3±2.2%, which was similar to when NaHS and CORM-2 were added where the cell 
viability was 88.0±1.9%. As for the CORM-2 pretreated cells, the cell viability 
(92.5±0.8%) was comparable to NaHS and ZnPP pretreated cells (93.0±0.7%). As for the 
group when CORM-2 and PAG were administered concurrently, the cell viability was 
85.9±0.5%. When PAG and ZnPP were added simultaneously, the cell viability was 
67.2±2.0%, which was similar to PAG (67.3±3.6%) pretreated only group. Finally for the 




Figure 16: Cell viability test for the different treatment groups. NC, normoxic control; HC, hypoxic 
control; 10μmol/L NaHS, sodium hydrogen sulphide; 10μmol/L PAG, Propargylglycine; 50μmol/L 
CORM-2 tricarbonyldichlororuthenium (II) dimmer; 10μM ZnPP, zinc protoporphyrin-IX. All the drug 
treatments were carried out under hypoxic conditions. The data shown are mean ± SD (n=6).* indicates 
p<0.05 compared to HC.  
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The anticipated result was that there should be interaction between H2S and CO. 
However the results were not observed, thus we propose that the 16 hours hypoxia 
treatment was insufficient to impose significant cellular damage. 
 
3.3 Assessment of cell damage via Lactate Dehydrogenase Assay (LDH) for 16 
hours hypoxia treatment 
For the assessment of the degree of cellular damage, the LDH levels for each of 
the treatment groups were expressed as a percentage compared with the NC. Statistical 
tests were then carried out with respect to the HC. The results in Figure 17 show that in 
HC, the LDH level was 1.67±0.1 fold higher than NC. After the addition of NaHS, the 
LDH level decreased to 1.08±0.01 fold. The cellular damage decreased drastically 
compared to the HC when both NaHS and CORM-2 were added, where the LDH level 
was 1.23±0.08 fold. On the other hand, when NaHS and ZnPP were added, the LDH level 
decreased to 1.05±0.01 fold, which was similar to the CORM-2 group (1.02±0.01 fold). 
As for the group when CORM-2 and PAG were administered alongside, the LDH level 
was 1.11±0.01 fold. Whereas when PAG and ZnPP were added simultaneously, the LDH 
level was much higher with a 1.72±0.07 fold, depicting a high degree of cellular damage. 
The extent of damage was comparable when PAG was added individually, with 
1.91±0.05 fold. Finally for the last group where ZnPP was added only, the LDH level 
was 1.40±0.07 fold. 
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Similarly, the predicted result was that both H2S and CO should work with each 
other. However the results were not expected, probably because the 16 hours hypoxia 





3.4 To determine amount of hydrogen sulphide (H2S) produced via H2S assay for 
16 hours hypoxia treatment 
 To evaluate the amount of H2S produced in the cell medium for each treatment 
group, H2S assay was implemented. From Figure 18, it was noted that in HC, the H2S 
concentration decreased from 81.7±1.5μM to 62.2±0.9μM. After the addition of NaHS, a 
source of exogenous H2S, the H2S concentration increased to 107±2.4μM. With a 
combination of both NaHS and CORM-2, the H2S concentration increased to an even 
higher level of 109±3.8μM. On the other hand, when NaHS and ZnPP were added, the 
Figure 17: Relative lactate dehydrogenase (LDH) production for different treatment groups. NC, 
normoxic control; HC, hypoxic control; 10μmol/L NaHS, sodium hydrogen sulphide; 10μmol/L PAG, 
Propargylglycine; 50μmol/L CORM-2 tricarbonyldichlororuthenium (II) dimmer; 10μM ZnPP, zinc 
protoporphyrin-IX. The drug treatments were all carried out under hypoxic conditions. Levels of LDH 
for each treatment group produced were expressed as a percentage of that induced by NC. Statistical 
test was performed for all treatment groups with respect to HC. The data shown are mean ± SD (n=6).* 
indicates p<0.05 compared to HC. 
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H2S concentration decreased to 77.8±2.6μM. As for the CORM-2 group, it had a 
relatively low H2S concentration of 56.5±1.8μM. As for the group when CORM-2 and 
PAG were administered concurrently, the H2S concentration was 72.6±2.8μM. Whereas 
when PAG and ZnPP were added simultaneously, the H2S concentration was lower with 
69.2±2.6μM, depicting the successful suppression of endogenous H2S. The extent of 
inhibition of H2S was similar when PAG was added individually, yielding a H2S 
concentration of 58.8±1.4μM. Surprisingly, for the last group where ZnPP was added 
only, the H2S concentration was elevated considerably to 137±0.9μM. 
However the results did not depict that H2S and CO work synergistically with 
each other. Thus we propose that the 16 hours hypoxia treatment was insufficient to 





Figure 18: Concentration of H2S produced by each treatment group. NC, normoxic control; HC, 
hypoxic control; 10μmol/L NaHS, sodium hydrogen sulphide; 10μmol/L PAG, Propargylglycine; 
50μmol/L CORM-2 tricarbonyldichlororuthenium (II) dimmer; 10μM ZnPP, zinc protoporphyrin-IX. 
All the drug treatment groups were carried out under hypoxic conditions. The data shown are mean ± 
SD (n=6).* indicates p<0.05 compared to HC.  
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3.5 Reverse transcription polymerase chain reaction (RT-PCR) on cystathionine-
gamma-lyase gene (CSE) for 16 hours hypoxia treatment 
After the determination of H2S concentration, RT-PCR was carried out. The 
rationale of running the gel was to inspect CSE gene expression. The RT-PCR 
experiments were repeated three times independently for each data point, to evaluate the 
reproducibility of the data. Below in Figure 19, it depicted the standardization for the 
different treatment groups with the house keeping gene GAPDH. After the 
standardization, running of the gel with the gene of interest, CSE was implemented, as 







The relative CSE mRNA level for the NC was defined as 100%. From Figure 21, 
in HC, the CSE mRNA level decreased to 63.3±0.09%. For the NaHS group, the CSE 
Figure 19: Standardization of GAPDH.  The drug 
treatments were all performed under hypoxic conditions. This 
was to facilitate the normalization of mRNA levels of CSE to 
the amount of GAPDH in each respective group. The size of 
the PCR product was 349bp. 
Figure 20: Gene expression for CSE. The drug treatments 
were all performed under hypoxic conditions. mRNA levels 
of CSE were normalized to the amount of GAPDH for each 
treatment group respectively. 
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mRNA level decreased to 28.3±0.3%, which implied that the exogenous supply of H2S 
was adequate for the mitigation of hypoxic cellular damage, thus leading to a decrease in 
the endogenous H2S. With a combination of both NaHS and CORM-2, the CSE mRNA 
level increased to a higher level of 59.7±0.4%. On the other hand, when NaHS and ZnPP 
were added, the CSE mRNA level was 77.1±0.6%. As for the CORM-2 group, it had a 
relatively low CSE mRNA level of 44.8±0.5%. When CORM-2 and PAG were 
administered concurrently, the CSE mRNA level was 64.2±0.3%. Whereas when PAG 
and ZnPP were added simultaneously, the CSE mRNA level was 64.7±0.4%. The extent 
of inhibition of H2S was successful when PAG was added individually, with CSE mRNA 
level of 42.2±0.5%. Surprisingly, for the last group where ZnPP was added only, the CSE 







Figure 21: Relative CSE mRNA level (%NC). NC, normoxic control; HC, hypoxic control; 10μmol/L 
NaHS, sodium hydrogen sulphide; 10μmol/L PAG, Propargylglycine; 50μmol/L CORM-2 
tricarbonyldichlororuthenium (II) dimmer; 10μM ZnPP, zinc protoporphyrin-IX Quantitative RT-PCR 
for CSE was performed. 10μl of PCR products from various treatment were loaded onto 1.5% agarose 
gel, stained with ethidium bromide. The sizes of the PCR products for GADPH and CSE are 349bp and 
445bp respectively. In this case, the mRNA levels of CSE were normalized to the amount of GAPDH 
for the different treatment groups. The data given were mean ± SD (n=6).* indicates p<0.05 compared 
to NC. RT- PCR was repeated three times independently for each data point. 
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From the above results, the relationship between H2S and CO was not established 
clearly. This meant that the 16 hours hypoxia treatment was not ample to illustrate the 
efficiency of the drug treatments and inflict significant cellular damage. 
3.6 Reverse transcription polymerase chain reaction (RT-PCR) on heme 
oxygenase-1 gene (HO-1) for 16 hours hypoxia treatment 
After investigation of CSE gene, RT-PCR on HO-1 was carried out. The RT-PCR 
experiments were repeated three times independently for each data point. Below in 
Figure 22, the standardization for the different treatment groups with the house keeping 
gene GAPDH was shown. After which, running of the gene of interest, HO-1, was 










Figure 22: Standardization of GAPDH.  The drug 
treatments were all performed under hypoxic conditions. This 
was to facilitate the normalization of mRNA levels of HO-1 
to the amount of GAPDH in each respective group. The size 
of the PCR product was 349bp. 
Figure 23: Gene expression for HO-1. The drug treatments 
were all performed under hypoxic conditions. mRNA levels 
of HO-1 were normalized to the amount of GAPDH for each 
treatment group respectively. 
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The relative HO-1 mRNA level for the NC was defined as 100%. From Figure 24, 
it was seen that in contrast, the HC HO-1 mRNA level was 66.9±0.2%. For the NaHS 
group, the HO-1 mRNA level was 146±0.5%. Interestingly, with a combination of both 
NaHS and CORM-2, the HO-1 mRNA level was increased to almost double level of 
259±1.4% compared to when only NaHS was added. On the other hand, when NaHS and 
ZnPP were added, the HO-1 mRNA level was 126±0.2%. As for the CORM-2 group, 
which yielded the source of exogenous CO, it had a HO-1 mRNA level of 135±0.4%. 
When CORM-2 and PAG were administered concurrently, the HO-1 mRNA level was 
145±0.3%. Whereas when PAG and ZnPP were added simultaneously, the HO-1 mRNA 
level was 113±0.2%.  However, when PAG was added individually, the HO-1 mRNA 
level increased drastically to 320±1.1%, proposing that the cells increased its endogenous 
HO-1 to overcome the inflicted hypoxic cellular damage. Finally, for the last group when 













Although there is some evidence to demonstrate the relationship between H2S and 
CO, it was still unclear. This implied that the 16 hours hypoxia treatment was not 
sufficient to prove the efficiency of the drug treatments and inflict significant cellular 
damage. 
3.7 Cells subjected to 24 hours hypoxia treatment 
The cells when treated with 16 hour hypoxia depicted that there might be 
relationship between NaHS and CORM-2; however the results were not ideal. Thus we 
proposed that probably the hypoxia duration should be prolonged to inflict greater 
cellular damage and investigate if the results were more considerable and significant. 
Figure 24: Relative HO-1 mRNA level (%NC). NC, normoxic control; HC, hypoxic control; 
10μmol/L NaHS, sodium hydrogen sulphide; 10μmol/L PAG, Propargylglycine; 50μmol/L CORM-2 
tricarbonyldichlororuthenium (II) dimmer; 10μM ZnPP, zinc protoporphyrin-IX Quantitative RT-PCR 
for CSE was performed. 10μl of PCR products from various treatment were loaded onto 1.5% agarose 
gel, stained with ethidium bromide. The sizes of the PCR products for GADPH and HO-1 are 349bp 
and 1043bp respectively. In this case, the mRNA levels of HO-1 were normalized to the amount of 
GAPDH for the different treatment groups. The data given were mean ± SD (n=6).* indicated p<0.05 
compared to NC. RT- PCR was repeated three times independently for each data point 
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Fortunately, when 24 hours of hypoxic treatment was inflicted on the cells, the data did 
prove that NaHS and CORM-2 indeed had an intricate relationship, probably working 
synergistically. 
3.8 Cell Viability test via Trypan blue exclusion for 24 hours hypoxia treatment 
From Figure 25, it showed that in the HC, the cell viability decreased from 
94.5±0.6% to 50.0± 0.9%. After the addition of NaHS, the cell viability increased to 
54.0±0.8%. Similarly, when CORM-2 was added only, the cell viability was 55.0±0.8%. 
Interestingly, when both NaHS and CORM-2 were added, the cell viability almost 
doubled to 91.2±1.6%, showing an alleviation of the hypoxic cellular injury, compared to 
when NaHS or CORM-2 was added individually. As for when NaHS and ZnPP were 
added, the cell viability was comparable to when only NaHS was added only, with cell 
viability of 60.3±1.0%. As for the group when CORM-2 and PAG were administered 
concurrently, the cell viability was 60.2±1.0%. The worst situation was when PAG and 
ZnPP were added simultaneously, the cell viability was 37.0±0.8%, showing that this 
combination had inhibited endogenous H2S and CO production. As for when PAG was 
added individually, the cell viability was 42.8±1.1%. Finally for the last group where 










3.9 Assessment of cell damage via Lactate Dehydrogenase Assay (LDH) for 24 
hours hypoxia treatment 
To confirm the reliability of cell viability data, LDH assay was implemented. Cell 
viability should have an inverse relationship with LDH assay, which meant that if the cell 
viability was high, LDH level should be low, implying that the cellular damage was low. 
This was true when applied vice versa too. For the assessment of the degree of cellular 
damage, the LDH levels for each of the treatment groups were expressed as a percentage 
compared with the NC. Statistical tests were then carried out with respect to the HC.  
Figure 25: Cell viability test for the different treatment groups. NC, normoxic control; HC, hypoxic 
control; 10μmol/L NaHS, sodium hydrogen sulphide; 10μmol/L PAG, Propargylglycine; 50μmol/L 
CORM-2 tricarbonyldichlororuthenium (II) dimmer; 10μM ZnPP, zinc protoporphyrin-IX. All the drug 
treatments were carried out under hypoxic conditions. The data shown are mean ± SD (n=6).* indicates 




From Figure 26, in the HC, the LDH level was 2.76±0.1 fold higher than NC. 
After the addition of NaHS, the LDH level decreased to 2.23±0.02 fold.  As for the group 
when CORM-2 was added only, the LDH level was 2.20±0.01 fold. Interestingly, when 
both NaHS and CORM-2 were added, the LDH level was approximately halved to 
1.35±0.08 fold, compared to when the cells were treated with NaHS or CORM-2 
individually. As for when NaHS and ZnPP were added, the LDH level was analogous to 
when only NaHS was added, with LDH level of 1.80±0.1 fold. As for the group when 
CORM-2 and PAG were administered in tandem, the LDH level was 1.80±0.1 fold, 
comparable to the group where NaHS and ZnPP were added. Whereas when PAG and 
ZnPP were added simultaneously, the LDH level increased drastically to 2.98±0.07 fold, 
portraying a high degree of hypoxic cellular damage, probably due to the deprivation of 
both endogenous H2S and CO. The extent of damage was also observable when PAG was 
added individually, with LDH level of 2.82±0.01 fold. Finally for the last group where 













3.10 To determine amount of hydrogen sulphide (H2S) produced via H2S assay for 
24 hours hypoxia treatment 
To examine the interaction of H2S and CO, it is imperative to assess the amount 
of H2S produced in the cell medium for each treatment group. From Figure 27, it was 
found that in the HC, the H2S concentration decreased from 81.8±0.2μM to 62.2±0.9μM. 
With the addition of NaHS, a source of exogenous H2S, the H2S concentration increased 
to 89.0±1.7μM. As for the group with CORM-2, the H2S concentration was 68.3±1.7μM. 
With the addition of both NaHS and CORM-2, the H2S concentration augmented to a 
Figure 26: Relative lactate dehydrogenase (LDH) production for different treatment groups. NC, 
normoxic control; HC, hypoxic control; 10μmol/L NaHS, sodium hydrogen sulphide; 10μmol/L PAG, 
Propargylglycine; 50μmol/L CORM-2 tricarbonyldichlororuthenium (II) dimmer; 10μM ZnPP, zinc 
protoporphyrin-IX. The drug treatments were all carried out under hypoxic conditions. Levels of LDH for 
each treatment group produced were expressed as a percentage of that induced by NC. Statistical test was 
performed for all treatment groups with respect to HC. The data shown are mean ± SD (n=6).* indicates 
p<0.05 compared to HC. # indicates p<0.01 compared to NaHS. ## indicates p<0.01 compared to CORM-2. 
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higher level of 145±1.9μM, which was increased twice in comparison with when NaHS 
or CORM-2 was added individually. When NaHS and ZnPP were added, the H2S 
concentration was 87.0±1.5μM. As for the group when CORM-2 and PAG were 
administered concurrently, the H2S concentration was 61.1±2.2μM. As for the cells 
treated with PAG and ZnPP, the H2S concentration plunged to 44.5±0.9μM, having 
successfully inhibited endogenous H2S. The degree of inhibition of H2S was similar when 
PAG was added individually, with H2S concentration of 55.1±0.9μM. Finally, in the 











Figure 27: Concentration of H2S produced by each treatment group. NC, normoxic control; HC, 
hypoxic control; 10μmol/L NaHS, sodium hydrogen sulphide; 10μmol/L PAG, Propargylglycine; 
50μmol/L CORM-2 tricarbonyldichlororuthenium (II) dimer; 10μM ZnPP, zinc protoporphyrin-IX. All 
the drug treatment groups were carried out under hypoxic conditions. The data shown are mean ± SD 
(n=6).* indicates p<0.05 compared to HC. # indicates p<0.01 compared to NaHS. ## indicates p<0.01 
compared to CORM-2. 
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3.11 To determine cystathionine-gamma-lyase (CSE) activity via CSE activity 
assay for 24 hours hypoxia treatment 
 After the H2S concentration had been found out, it was crucial to investigate if the 
amount of H2S was correlated to the CSE activity. The principle involved was that CSE 
activity is expressed in terms of (μmol/ml)/g, where it was based on the amount of H2S 
(μmol/ml) produced per amount of protein produced (g). 
 Figure 28 shows that in the HC, the CSE activity decreased from 98.3±0.6 
(μmol/ml)/g to 72.7±0.6 (μmol/ml)/g. For the cells treated with NaHS which was 
responsible for the production of exogenous H2S, the CSE activity was elevated to 
77.0±0.15 (μmol/ml)/g. As for the group treated with CORM-2, the CSE activity was 
71.3±0.01 (μmol/ml)/g. Most importantly, when both NaHS and CORM-2 were 
administered, the CSE activity augmented to a higher level of 144±1.1 (μmol/ml)/g, 
approximately twice compared to when NaHS or CORM-2 was added individually. On 
the other hand, for the cells treated with NaHS and ZnPP, the CSE activity was 59.6±2.9 
(μmol/ml)/g. As for the group when CORM-2 and PAG were administered, the CSE 
activity was 64.1±6.3 (μmol/ml)/g. As for the group treated with both PAG and ZnPP, the 
CSE activity diminished to 11.0±0.01 (μmol/ml)/g, implying that endogenous H2S 
production was effectively inhibited. Next, for the group when PAG was added 
individually, the CSE activity was 40.1±0.01 (μmol/ml)/g. Lastly, in the ZnPP treated 











3.12 To determine Heme oxygenase (HO) activity via HO activity assay for 24 
hours hypoxia treatment 
HO activity was determined by the amount of bilirubin formed and expressed as 
pmol of bilirubin formed per mg of cell protein in 60 minutes. The protein content was 
then measured by a dye-binding assay (Bio-Rad). In this experiment, the basis was to 
firstly detect the amount of bilirubin produced for respective groups.  
From Figure 29, it was found that in the HC, the HO activity was 93±0.02 (pmol 
bilirubin/mg/h). For the cells treated with NaHS, it also had HO activity of 106±0.02 
(pmol bilirubin/mg/h). For the group treated with CORM-2, the HO activity was elevated 
to 137±0.02 (pmol bilirubin/mg/h). Most prominently was when both NaHS and CORM-
2 were administered, the HO activity augmented to a higher level of 173±0.02 (pmol 
Figure 28: CSE activity (μmol/ml)/g. NC, normoxic control; HC, hypoxic control; 10μmol/L NaHS, 
sodium hydrogen sulphide; 10μmol/L PAG, Propargylglycine; 50μmol/L CORM-2 
tricarbonyldichlororuthenium (II) dimmer; 10μM ZnPP, zinc protoporphyrin-IX. All the drug treatment 
groups were carried out under hypoxic conditions. The data shown are mean ± SD (n=6).* indicates 




bilirubin/mg/h), a few fold higher than the activity as compared to when NaHS or 
CORM-2 was administered individually. As for when NaHS and ZnPP were added, the 
HO activity was 126±0.04 (pmol bilirubin/mg/h). Next, for the group when CORM-2 and 
PAG were administered, the HO activity was 118±0.01 (pmol bilirubin/mg/h). On the 
other hand, when PAG and ZnPP were added concurrently, the HO activity diminished to 
58±0.2 (pmol bilirubin/mg/h), suggesting that ZnPP had effectively inhibited endogenous 
CO. When PAG was added only, the HO activity was surprisingly elevated to 125±1.0 
(pmol bilirubin/mg/h). Lastly, in the final group treated with ZnPP which inhibited the 












Figure 29: HO activity (pmol of bilirubin formed per mg of cell protein in 1 hour). NC, normoxic 
control; HC, hypoxic control; 10μmol/L NaHS, sodium hydrogen sulphide; 10μmol/L PAG, 
Propargylglycine; 50μmol/L CORM-2 tricarbonyldichlororuthenium (II) dimmer; 10μM ZnPP, zinc 
protoporphyrin-IX. All the drug treatment groups were carried out under hypoxic conditions. The data 
shown are mean ± SD (n=6).* indicates p<0.05 compared to HC. # indicates p<0.01 compared to 
NaHS. ## indicates p<0.01 compared to CORM-2. 
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3.13 Reverse transcription polymerase chain reaction (RT-PCR) on cystathionine-
gamma-lyase gene (CSE) for 24 hours hypoxia treatment  
The RT-PCR experiments were repeated three times independently for each data 
point. Figure 30 depicts the standardization for the different treatment groups for CSE 
against the house keeping gene GAPDH. After which, RT-PCR with the gene of interest, 
CSE, was implemented, as seen in Figure 31. 
The relative CSE mRNA level for the NC was defined as 100%. From Figure 32, 
the HC CSE mRNA level decreased to 51.7±0.03%. For the NaHS group, the CSE 
mRNA level decreased to 30.9±0.2%, signifying that the exogenous H2S was sufficient 
for the lessening of hypoxic cellular damage, thus the CSE mRNA level detected was 
low. Although there is enough H2S production, CSE activity increased probably to further 
compensate the inflicted hypoxic damage. As for the group with CORM-2, the CSE 
mRNA level was 34.8±0.2%. The most crucial data was when both NaHS and CORM-2 
were added, the CSE mRNA level increased to a high level of 68.0±0.4 %, almost double 
fold compared to when NaHS or CORM-2 was added independently. On the other hand, 
when NaHS and ZnPP were added, the CSE mRNA level was 47.2±0.3%. When CORM-
2 and PAG were administered, the CSE mRNA level was 28.2±0.2%. Whereas when 
PAG and ZnPP were added simultaneously, the CSE mRNA level diminished to 
17.4±0.1%, proving the fact of successful inhibition of the CSE gene. The inhibition of 
CSE was also successful when PAG was added individually, with CSE mRNA level of 
33.8±0.2%. Finally, for the last group where ZnPP was added only, the CSE mRNA level 
was elevated drastically to 103±0.2%. 
 75
 













Figure 30: Standardization of GAPDH.  The 
drug treatments were all performed under hypoxic 
conditions. This was to facilitate the normalization 
of mRNA levels of CSE to the amount of GAPDH 
in each respective group. The size of the PCR 
product was 349bp. 
Figure 31: Gene expression for CSE. The drug 
treatments were all performed under hypoxic 
conditions. mRNA levels of CSE were normalized 
to the amount of GAPDH for each treatment group 
respectively 
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3.14 Reverse transcription polymerase chain reaction (RT-PCR) on heme 
oxygenase-1 gene (HO-1) for 24 hours hypoxia treatment 
Below in Figure 33, the standardization for the different treatment groups with the 
house keeping gene GAPDH was shown. In Figure 34, running of the gene of interest, 
HO-1, was implemented. 
 
 
Figure 32: Relative CSE mRNA level (%NC). NC, normoxic control; HC, hypoxic control; 10μmol/L 
NaHS, sodium hydrogen sulphide; 10μmol/L PAG, Propargylglycine; 50μmol/L CORM-2 
tricarbonyldichlororuthenium (II) dimmer; 10μM ZnPP, zinc protoporphyrin-IX Quantitative RT-PCR 
for CSE was performed. 10μl of PCR products from various treatment were loaded onto 1.5% agarose 
gel, stained with ethidium bromide. The sizes of the PCR products for GADPH and CSE are 349bp and 
445bp respectively. In this case, the mRNA levels of CSE were normalized to the amount of GAPDH 
for the different treatment groups. The data given were mean ± SD (n=6).* indicates p<0.05 compared 
to NC. # indicates p<0.01 compared to NaHS. ## indicates p<0.01 compared to CORM-2. RT- PCR 










From Figure 35, in the HC, the HO-1 mRNA level decreased to 21.7±0.14 % 
compared to the NC of 100%. For the NaHS treatment group, it also had HO-1 mRNA 
level of 50.7±0.36 %. As for the group with CORM-2, the HO-1 mRNA level was 
51.3±0.3 %. The most vital data was when both NaHS and CORM-2 were added, the 
HO-1 mRNA level amplified to a high level of 152±0.8 %, almost triple the activity as 
compared to when NaHS or CORM-2 was added separately. In contrast, for the NaHS 
and ZnPP treated group, the HO-1 mRNA level was 46.6±0.4 %. Next, for the cells 
administered with both CORM-2 and PAG were administered, the HO activity was 
48.8±0.4 %. As for the group of when PAG and ZnPP were added in tandem, the HO-1 
mRNA level diminished to 17.0±0.2%, meaning that the endogenous CO was effectively 
inhibited by ZnPP. When PAG was added only, the HO-1 mRNA level was startlingly 
Figure 33: Standardization of GAPDH.  The drug 
treatments were all performed under hypoxic 
conditions. This was to facilitate the normalization of 
mRNA levels of HO-1 to the amount of GAPDH in 
each respective group. The size of the PCR product was 
349bp. 
Figure 34: Gene expression for HO-1. The drug 
treatments were all performed under hypoxic 
conditions. mRNA levels of HO-1 were normalized to 
the amount of GAPDH for each treatment group 
respectively. 
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elevated to 201±1.0%. Finally, when ZnPP was added to inhibit the HO gene, the HO-1 








3.15 To investigate CSE protein via Immunohistochemical Staining for 24 hours 
hypoxia treatment 
Immunohistochemical staining is a method to show the expression level of the 
regulation of target proteins. For the negative controls (that is without addition of 
antibodies) for all treatment groups (Figure 36 a, c, e, g, i, k, m, o, q, s), no positive 
Figure 35: Relative HO-1 mRNA level (%NC). NC, normoxic control; HC, hypoxic control; 
10μmol/L NaHS, sodium hydrogen sulphide; 10μmol/L PAG, Propargylglycine; 50μmol/L CORM-2 
tricarbonyldichlororuthenium (II) dimmer; 10μM ZnPP, zinc protoporphyrin-IX Quantitative RT-PCR 
for CSE was performed. 10μl of PCR products from various treatment were loaded onto 1.5% agarose 
gel, stained with ethidium bromide. The sizes of the PCR products for GADPH and HO-1 are 349bp 
and 1043bp respectively. In this case, the mRNA levels of HO-1 were normalized to the amount of 
GAPDH for the different treatment groups. The data given were mean ± SD (n=6).* indicated p<0.05 
compared to NC. # indicates p<0.01 compared to NaHS. ## indicates p<0.01 compared to CORM-2. 
RT- PCR was repeated three times independently for each data point. 
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staining was detected. For the different treatment groups, positive staining was detected. 
For the NC (Figure 36b), moderate positive staining of CSE was seen. For HC (Figure 
36d), it has weak positive staining of CSE. As for NaHS treated group (Figure 36f), 
strong signal of CSE was seen. For the group administered with NaHS and CORM-2 
(Figure 36h), it had the strongest signal of CSE. Next for the NaHS and ZnPP treated 
group (Figure 36j); there was strong signal of CSE. For the cells treated with CORM-2 
(Figure 36l), there was moderate positive staining of CSE. As for the CORM-2 and PAG 
treatment group (Figure 36n), weak positive staining of CSE was detected. Then for PAG 
and ZnPP treated group (Figure 36p), it had the weakest positive staining of CSE. As for 
the group where PAG (Figure 36r) was added only, weak positive staining of CSE was 
distinguished. Finally, for the group with ZnPP only (Figure 36t), weak positive staining 
of CSE was identified.  
Immunohistochemical Staining of CSE in each treatment group:         
 
                                                                                    
a) Negative control: Normoxic control (NC)                            b) Normoxic control (NC)  
 
                                                         
c) Negative control: Hypoxic control (HC)                               d) Hypoxic control (HC) 
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e) Negative control: NaHS                                                          f) NaHS 
 
                                                           
g) Negative control: NaHS and CORM-2                                   h) NaHS and CORM- 2 
 
                                                           
i) Negative control: NaHS and ZnPP                                          j) NaHS and ZnPP 
 
                                                           




                                                           
m) Negative control: CORM-2 and PAG                                    n) CORM-2 and PAG 
                                                                
                                                           
o) Negative control: PAG and ZnPP                                           p) PAG and ZnPP 
 
                                                           
q) Negative control: PAG                                                            r) PAG 
 
                                                                        





Figure 36: Light photomicrographs (          = 20μm) of VSMCs after CSE antibody staining. On 
the left column (a,c,e,g,i,k,m,o,q,s) are negative controls of all treatment groups, where no positive 
stainings were detected. On the right column (b,d,f,h,j,l,n,p,r,t) are the different treatment groups, where 
the positive staining was depicted by arrows. 
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3.16 To investigate heme oxygenase-1 gene (HO-1) protein via 
Immunohistochemical Staining for 24 hours hypoxia treatment 
 
Immunohistochemical staining is essential to show the expression level of the 
regulation of target genes. No positive staining of any protein product of targeted gene 
was observed in the negative control (that is without addition of antibodies) from each 
treatment group (Figure 37 a, c, e, g, i, k, m, o, q, s). For the different treatment groups 
shown below in the right column, positive staining was identified. For the NC (Figure 
37b), moderate positive staining of HO-1 was seen. For HC (Figure 37d), it showed weak 
positive staining of HO-1. Next, for the NaHS treated group (Figure 37f), moderate signal 
of HO-1 was detected. As for the cells treated with both NaHS and CORM-2 (Figure 
37h), it had the strongest signal of HO-1. Next when NaHS and ZnPP were added (Figure 
37j), weaker signal of HO-1 was identified. For CORM-2 treated group (Figure 37l), 
there was strong positive staining of HO-1. As for the CORM-2 and PAG treatment 
group (Figure 37n), strong positive staining of HO-1 was detected. Then for PAG and 
ZnPP treated group (Figure 37p), it had the weakest positive staining of HO-1.  As for the 
group where PAG (Figure 37r) was added only, weak positive staining of HO-1 was 
detected. Finally, for the group with ZnPP only (Figure 37t), weak positive staining of 













Immunohistochemical Staining of HO-1 in each treatment group:     
 
                                                           
a) Negative control: Normoxic control (NC)                              b) Normoxic control (NC)  
 
                                                           
c) Negative control: Hypoxic control (HC)                                 d) Hypoxic control (HC) 
 
                                                           
e) Negative control: NaHS                                                           f)NaHS 
 
                                                           
g) Negative control: NaHS and CORM-2                                    h) NaHS and CORM- 2 
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i) Negative control: NaHS and ZnPP                                          j) NaHS and ZnPP 
 
                                                           
k) Negative control: CORM-2                                                     l) CORM-2 
 
                                                           
m) Negative control: CORM-2 and PAG                                    n) CORM-2 and PAG 
 
                                                           




                                                           
q) Negative control: PAG                                                             r) PAG 
 
                                                           











Figure 37: Light photomicrographs (          = 20μm) of VSMCs after HO-1 antibody staining. On 
the left column (a,c,e,g,i,k,m,o,q,s) are negative controls of all treatment groups, where no positive 
staining was detected. On the right column (b,d,f,h,j,l,n,p,r,t) are the different treatment groups, where 




4.1 Role of H2S in alleviation of cellular damage in ischemic diseases 
The purpose of this study was to investigate how H2S exerts its role in the 
alleviation of cellular damage in ischemic diseases. It had been proposed by Zhu et al. 
(2007) that exogenous H2S administered to VSMCs increased cell viability and decreased 
LDH levels, whereby both were correlated to the respective production of H2S. As 
demonstrated in our previous publication in Zhu et al. (2007), the increased hypoxic 
cellular death was attenuated by the pretreatment of NaHS (85 ±1.8%). Whereas with 
PAG pretreatment (62.2 ± 2.1%), with effective inhibition of endogenous H2S, the cell 
viability decreased significantly. Furthermore, the cell viability correlates with the LDH 
levels, whereby when the cell viability was high, the LDH level was low. This was true 
vice versa. To further validate the protective role of H2S in ischemic disease, H2S assay 
was implemented. In the NaHS pretreatment group (107.6 ± 5.3μM), the H2S content was 
the highest. As for the group treated with PAG (69.3± 1.2μM), the H2S level was 
inhibited successfully (Zhu et al, 2007). However the exact mechanism of how H2S 
works is still unknown.  
Firstly, it is imperative to discern which enzyme is responsible for the production 
of H2S in the cardiovascular system, which permits H2S to exert its cardio protective 
effects. Generally, H2S is produced mainly via two enzymes namely: CBS and CSE in 
mammalian tissue. CBS does not contribute to H2S generation in cardiovascular system 
under physiological conditions (Wang, 2002). This prompted CSE to be the principal 
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gene to be analyzed in this experiment involving H2S generation. It has been well 
established that NaHS is the most appropriate source of H2S. As discussed by Du et al. 
(2004), the reasons to support that NaHS is a good source of H2S are as follow: Firstly, 
NaHS dissociates to Na+ and HS- in solution, followed by HS- association with H+ and 
thus finally producing H2S. This chemical reaction occurs despite in H2S solution or by 
dissolving NaHS. Secondly, as opposed to gaseous state of H2S, NaHS dissolved in 
solution allows for easy manipulation for the quantification of the desired H2S 
concentration (Du et al., 2004). 
There are many evidences that prove the protective effects of H2S on IHD. Other 
than the discovery by Zhu et al. (2007) that exogenous source of H2S could in fact 
increase cell viability to a level of 85 ±1.8% compared to hypoxic control group of 
71±1.2% cell viability. Another source of evidence come from in vivo studies, that an 
intravenous bolus of H2S could decrease the blood pressure by a significant level of 12-
30mmHg (Wang, 2002). In fact, the protective effect exerted by H2S is also established in 
neurological models. It was found that in H2S mediated LTP, H2S did not require any 
NMDA receptors activation in exerting long-term enhancement nor did it increase 
intracellular cyclic GMP. Furthermore, it was discovered that at physiological levels, H2S 
could selectively increase NMDA receptor-mediated responses (Abe and Kimura, 2002). 
As to the probable mechanism of how H2S exerts its cardio-protective effects, 
there were various mechanisms being put forward. One being from Zhang et al. (2001), 
which suggests that the role of H2S in isolated VSMCs was found to hyperpolarize 
 88
membrane by increasing KATP channel currents, and thus decreased blood pressure and 
alleviated MI conditions.   
But we propose that among the 3 well documented gasotransmitters, H2S may 
have an intricate relationship with CO. It may be that H2S and CO work synergistically, 
to exert its cardioprotective effects. Furthermore, our data have proven that they indeed 
work hand in hand in the mitigation of hypoxic cellular damage. 
4.1.1 Role of CO in alleviation of cellular damage in ischemic diseases 
 CO is produced mainly via HO-1 enzyme, which is a rate-limiting enzyme that 
degrades heme and consequently produces CO, bilirubin, and iron. These products have 
important physiological effects, especially CO. The most established exogenous source of 
CO is from CORMs. As characterized by Motterlini et al. (2005), these transition metal 
carbonyls work by the principle that certain ligands in a metal complex promote CO 
dissociation, either sterically or electronically or via photodissociation. 
It is also interesting to note that the cardiac distribution of HO-1 has been mainly 
identified in heart vascular wall but not in cardiomyocytes (Wu and Wang, 2004). It was 
shown that in a hypoxic cardiac model, there was up-regulation of HO-1 and 
consequently increased CO production. The increased CO level in fact led to increased 
cardiac blood supply via relaxation of vascular tone (Grilli et al., 2003). Other advantages 
of CO treatment include the capability to ameliorate inflammation, vascular dysfunction, 
and reduce graft rejection in mouse-to-rat cardiac transplants (Motterlini et al., 2002). All 
the functions of CO are due to it having vasodilatory, anti-inflammatory, antiapoptotic 
and immunomodulatory properties (Ryter and Otterbein, 2004). 
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As for the mechanism of how CO works, there are some mechanisms being 
proposed. One being that CO binds to the iron of heme proteins and subsequently 
affecting various intracellular signaling pathways namely: soluble guanylyl cyclase, 
mitogen-activated protein kinases (MAPK) and the antioxidant enzyme manganese 
superoxide dismutase (Kapturczak and Agarwal, 2006). Another mechanism of how CO 
works is put  forward by Leffler et al. (2006), who proposed that CO dilates arterioles via 
binding to heme which is bound to large conductance Ca2+ activated K+ channels (BKCa 
channels). After which it increases Ca2+ channel sensitivity, thus increases coupling of 
Ca2+ sparks to BKCa channel openings and subsequently hyperpolarizes the vascular 
smooth muscle. 
However the controversy arises that although gaseous CO is cytoprotective both 
in vitro and in vivo, at higher concentrations of CO, it causes hemoglobin saturation and 
tissue hypoxia (Kapturczak and Agarwal, 2006). 
With all the above evidences proving that at appropriate doses of CO alone does 
promote cardioprotection, it is imperative to find out if both H2S and CO does work 
synergistically in the amelioration of hypoxic cellular injury. In addition, we need to 
investigate if H2S exerts its cardioprotective effect via the interaction with CO. 
4.1.2 Does H2S and CO work synergistically in alleviation of cellular damage in 
ischemic diseases? 
The relationship between H2S and CO is not fully understood and it is novel, 
especially in the area of ischemic diseases. A plausible explanation for the interaction 
between H2S and CO was proposed by Zhang et al. (2004) in a HPH model. It was 
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initiated that when an inhibitor of H2S was added, the plasma H2S and plasma CO level, 
HO-1 protein and mRNA levels in pulmonary arteries decreased. It meant that H2S might 
be responsible for the pathogenesis of HPH through the up regulation of the CO/HO 
pathway (Zhang et al., 2004). 
Another explanation for the interaction between H2S and CO is that H2S can be 
scavenged by methemoglobin-containing molecules for example oxidized glutathione. It 
was proposed that in fact hemoglobin might be the common “sink” for CO in 
carboxyhemoglobin formation and for H2S in sulfhemoglobin formation. So if this sink 
was filled with one gas, the binding of other gases would be affected and thus the altering 
the availability of either H2S or CO and subsequently the action on targeted cells (Wang, 
2002).  
Another interesting finding is by Wang (2002), which has documented that H2S, 
NO and CO work synergistically to facilitate the induction of hippocampal LTP 
responsible for memory formation. The only difference in the mode of action is in the 
aspect of the requirement of NMDA receptors activation. 
With some plausible explanations for the interaction of H2S and CO, it is crucial 
to investigate if they in fact work synergistically in amelioration of hypoxic cellular 
injury. Furthermore, the data by other groups were focused mainly on in vivo models or 
neurological models. Thus our project is novel involving in vitro models and 
cardiovascular areas.  
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4.2 H2S and CO do not work synergistically for 16 hours hypoxia treatment 
The initial part of this experiment was to find out the appropriate doses for NaHS, 
PAG, ZnPP and CORM-2, after which suitable hypoxia treatment duration had to be 
determined. From pilot studies (data not shown), it was verified that 16 hours hypoxia 
treatment was suitable for the implementation of hypoxic experiments involving VSMCs.  
However, we later ascertained that 16 hours hypoxia duration was not sufficient, thus we 
performed our experiments with 24 hours hypoxic treatment. 
4.2.1 H2S and CO work synergistically for 16 hours hypoxia treatment as depicted 
in cell viability, LDH assay and H2S assay? 
Firstly, cell viability was carried out with the 16 hour hypoxia treatment for all the 
experimental groups with the appropriate dosages of drugs. To attain simulated MI 
conditions, a uniform hypoxic environment with low PO2 was provided by Modular 
Incubator Chamber (MIC-101TM).  
In the HC, the cell viability decreased from 94.5±0.6% to 70.7± 0.9%. 
Expectedly, the cell viability was correlated with the LDH level, indicative of the degree 
of cyto-toxicity, whereby the LDH level in HC was 1.67±0.1 fold higher than NC. It was 
noted that in the HC, the H2S concentration decreased from 81.7±1.5μM to 62.2±0.9μM, 
elucidating that due to the decrease in the H2S concentration in the HC, it led to a 
decrease in cell viability and increase in LDH level. 
To ameliorate the cellular injury inflicted by hypoxia, with pretreatment of NaHS 
and CORM-2 individually, the cell viability were 87.3±2.2% and 92.5±0.8% 
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respectively, which were analogous to when NaHS and CORM-2 (88.0±1.9%) were 
added. As for the LDH levels, the NaHS group (1.08±0.01 fold), CORM-2 (1.02±0.01 
fold) were comparable to when both NaHS and CORM-2 (1.23±0.08 fold) were added. 
Collectively, these data were associated with the H2S concentration, whereby for the 
NaHS pretreated group (107±2.4μM) was akin to when both NaHS and CORM-2 
(109±3.8μM) were added. As for CORM-2 pretreated group, the H2S concentration was 
lower with 56.5±1.8μM. Generally, for the above treatment groups, the cell viability was 
inversely related to the LDH levels. Moreover, mitigation of the hypoxic cellular injury 
was linked to elevated H2S concentration. However, the expected outcome was that when 
both NaHS and CORM-2 were added, there should be a few folds improvement in the 
amelioration of the hypoxic cellular injury than when NaHS or CORM-2 was added only. 
Hence it might be that 16 hours hypoxia duration was not sufficient for imposing 
significant cellular damage, thus not being able to illustrate the effects of the drugs. As a 
result, 24 hour hypoxia treatment was utilized. 
Next, when NaHS and ZnPP were added, the cell viability increased to 
93.0±0.7%, the LDH level was 1.05±0.01 fold and both data were correlated with H2S 
concentration of 77.8±2.6μM. As for the group when CORM-2 and PAG were 
administered concurrently, the cell viability was 85.9±0.5%, the LDH level was         
1.11±0.01 fold. Consequently, the decrease in cell viability compared to CORM-2 
(92.5±0.8%) was correlated with a decrease in H2S concentration of 72.6±2.8μM. 
When PAG and ZnPP were added simultaneously, the cell viability was 
67.2±2.0%, indicative of the large cellular damage with LDH level of 1.72±0.07 fold. 
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The deterioration of the cellular injury was correlated to a low H2S concentration of 
69.2±2.6μM. As for the group pretreated with PAG, with successful repression of 
endogenous H2S, the cell viability was only 67.3±3.6% and the LDH level was 1.91±0.05 
fold. The exacerbating cellular damage was due to a low H2S concentration of 
58.8±1.4μM. This PAG pretreatment group data is similar to Zhang et al. (2004) which 
discovered that in hypoxic rat models, when PAG was administered, the plasma H2S 
decreased significantly, the plasma CO and the HO-1 protein expression in pulmonary 
arteries were also significantly decreased. Finally for the last group where ZnPP was 
added only, with inhibition of the endogenous CO production, the cell viability was 
71.2±0.5%, LDH level was 1.40±0.07 fold. Interestingly, the H2S concentration was high 
with 137±0.9μM which implied that the cells increased its endogenous H2S content 
attempting to remove the detected cellular injury. 
4.2.2 H2S and CO work synergistically for 16 hours hypoxia treatment as depicted 
in H2S assay and CSE mRNA level? 
Next to investigate if the H2S concentration was correlated to the gene expression 
of CSE. As demonstrated by Geng et al. (2004), CSE mRNA expression was closely 
related to H2S production whereby the CSE mRNA level in rats’ myocardium was 24.4% 
higher than that in the thoracic aorta (Geng et al., 2004). Furthermore, they also 
investigated MI when induced by isoproterenol (Geng et al., 2004). Thus we performed 
RT-PCR in vitro to investigate the relationship between H2S production and CSE mRNA 
level. 
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Here, the relative CSE mRNA level for the NC was defined as 100%. Firstly, in 
the HC, the H2S concentration decreased to 62.2±0.9μM and it was correlated with a 
decrease in CSE mRNA to 63.3±0.09%. 
For the NaHS pretreated group, although the H2S concentration was 107±2.4μM, 
the CSE mRNA level decreased to 28.3±0.3%. The decrease in CSE mRNA level 
suggested that the exogenously added H2S was sufficient for the mitigation of hypoxic 
cellular damage, thus it was not essential to up regulate its endogenous CSE mRNA level. 
Furthermore, the high H2S concentration detected was indicative of the exogenous H2S 
level in the medium only. As for the CORM-2 pretreated group, it had a relatively low 
CSE mRNA level of 44.8±0.5% which was linked directly to detection of low H2S 
concentration of 56.5±1.8μM. Apparently, with a combination of both NaHS and CORM-
2, the CSE mRNA level increased to a higher level of 59.7±0.4%, related to a H2S 
concentration of 109±3.8μM. The anticipated outcome was that the CSE mRNA level 
should be a few folds higher compared to NaHS or CORM-2 pretreated only, if 
performed in a 24 hour hypoxia. A probable explanation might be that the 16 hours 
hypoxia exposure was not adequate for the detection of significant cellular damage.  
As for when NaHS and ZnPP were added, the CSE mRNA level was 77.1±0.6% 
and correlated with H2S concentration of 72.6±2.8μM. When the cells were pretreated 
with CORM-2 and PAG, the CSE mRNA level was 64.2±0.3% and it was correlated with 
H2S concentration of 77.8±2.6μM. 
 Whereas when PAG and ZnPP were added simultaneously, the CSE mRNA level 
was 64.7±0.4% and the H2S concentration was 69.2±2.6μM. Next with pretreatment of 
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PAG, the extent of inhibition of H2S was successful, as seen in the decrease in CSE 
mRNA level of 42.2±0.5% and also lower H2S concentration of 58.8±1.4μM. 
Surprisingly, for the last group pretreated with ZnPP only, the CSE mRNA level was 
augmented significantly to 94.8±1.2% which explained the detection of higher H2S 
concentration of 137±0.9μM. This was probably once the cells detected the hypoxic 
cellular damage inflicted by ZnPP; it increased the H2S production to compensate the 
damage. 
4.2.3 H2S and CO work synergistically for 16 hours hypoxia treatment as depicted 
in HO-1 mRNA level? 
Finally, after the detection of the CSE mRNA level, the HO-1 mRNA level was 
inspected too. It had been reported that the HO-1 mRNA level was closely linked with 
physiological stimuli such as hypoxia which could repress the HO-1 expression (Wu and 
Wang, 2005). 
Here, the relative HO-1 mRNA level for the NC was defined as 100%. The HC 
HO-1 mRNA level was 66.9±0.2%. For the NaHS pretreated only and CORM-2 
pretreated only groups, the HO-1 mRNA levels were146±0.5% and 135±0.4% 
respectively. Remarkably, with pretreatment of both NaHS and CORM-2, the HO-1 
mRNA level was doubled to 259±1.4%, as compared to when only NaHS or CORM-2 
was added. This group suggested that there may be interaction between H2S and CO and 
they may be working together in amelioration of the cellular damage. 
 96
Next, with the pretreatment of both NaHS and ZnPP, the HO-1 mRNA level was 
126±0.2%, which was lower than the group pretreated with NaHS (146±0.5%). This data 
demonstrated that ZnPP had effectively down regulated HO-1 mRNA level. When 
CORM-2 and PAG were administered concurrently, the HO-1 mRNA level was 
145±0.3%, higher than the CORM-2 pretreated group (135±0.4%).This meant that PAG 
had successfully repressed endogenous H2S, thus HO-1 mRNA level was increased to 
attempt to remove the cellular damage. 
Whereas for the cells pretreated with PAG and ZnPP, the HO-1 mRNA level was 
113±0.2%, showing that PAG is able to rescue HO-1 repression despite of ZnPP 
presence. Conversely, when PAG was added individually, the HO-1 mRNA level 
augmented significantly to 320±1.1%, suggesting that once the cells sensed the hypoxic 
cellular damage, it increased its endogenous HO-1. Finally, for the last group pretreated 
with ZnPP only, the HO-1 mRNA level detected was 54.6±0.3%, depicting successful 
inhibition of the gene. 
4.3 H2S and CO work synergistically for 24 hours hypoxia treatment 
With the data from the 16 hours hypoxia, there had been evidences that H2S and 
CO might be working synergistically to alleviate the cellular damage. However the 
relationship between them was not very apparent and the mechanism of how H2S works 
remains unknown. This was probably because the 16 hours hypoxia exposure was not 
adequate to inflict significant hypoxic cellular damage and consequently not being able to 
reflect the therapeutic effects of the drugs. Thus we propose to induce a 24 hours hypoxia 
treatment to investigate if H2S and CO has an intricate relationship in the amelioration of 
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the cellular injury. Here, similarly, we induced hypoxia via the Modular Incubator 
Chamber (MIC-101TM), so as to simulate MI conditions with a stable hypoxic 
environment with low PO2. 
4.3.1 H2S and CO work synergistically for 24 hours hypoxia treatment as depicted 
in cell viability, LDH assay and H2S assay 
Firstly, cell viability was investigated after the 24 hours hypoxia treatment for all 
the experimental groups being treated with the appropriate drug dosages. In the HC, the 
cell viability decreased from 94.5±0.6% to 50±0.9%. To verify the credibility of the data, 
LDH assay which was indicative of the potential cellular damage, was implemented. Cell 
viability results correlated with the LDH level, whereby the LDH level in HC was 
2.76±0.1 fold higher than NC. Both the cell viability and LDH level were related to the 
amount of H2S produced. This was evident in HC whereby the H2S concentration 
decreased from 81.8±0.2μM to 62.3±0.9μM. From the H2S levels, it seemed that due to 
the decrease in the H2S concentration in the HC, it led to decreased cell viability and 
increased LDH level. This was similar to our previous publication in Zhu et al. (2007) 
where cell death was increased under the stimuli of hypoxia (71±1.2%) as compared to 
NC (95±2.3%). 
To reduce the extent of cellular damage in mind, it was imperative to reduce the 
hypoxic cellular injury; the cells were then pretreated with NaHS and CORM-2 
individually. The cell death was abolished when pretreated with NaHS (54.0±0.8%) and 
CORM-2 (55.0±0.8%) individually. Interestingly, the cell viability increased several 
folds when both NaHS and CORM-2 (91.2±1.6%) were added. This suggests that NaHS 
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and CORM-2 were working synergistically, to alleviate the hypoxic cellular damage. 
LDH levels for the NaHS group (2.23±0.02 fold, p<0.05 vs. NaHS and CORM-2), 
CORM-2 group (2.20±0.01 fold, p< 0.05 vs. NaHS and CORM-2) were approximately 
doubled, compared to when both NaHS and CORM-2 (1.35±0.08 fold) were added. 
Furthermore, these data were linked to the H2S concentration, where for the NaHS 
pretreated group (90.0±1.7μM), CORM-2 pretreated group (68.3±1.7μM) were several 
folds lower compared to when both NaHS and CORM-2 (145±1.9μM) were added. This 
implied that for the NaHS and CORM-2 pretreated group, the H2S level was 1.6 fold 
higher than the NaHS pretreated group. As compared to the CORM-2 group, the NaHS 
and CORM-2 pretreated group was 2.1 fold higher. These data proved that when 
pretreated with NaHS and CORM-2 had a few folds improvement in the attenuation of 
the hypoxic cellular injury compared to when NaHS or CORM-2 was added only. This 
result is comparable to Zhang et al. (2004) when NaHS was added in hypoxic in vivo 
models, the plasma H2S and CO, HO-1 protein expression in pulmonary arteries were 
also significantly augmented. However the experimental treatment groups in Zhang et al. 
(2004) were slightly different and it was performed in rats. 
Next, when NaHS and ZnPP were administered, the cell viability increased to 
60.3±1.0%, the LDH level was 1.80±0.1 fold and both data were correlated with H2S 
concentration of 87.0±1.5μM. There was an increase in cell viability compared to NaHS 
(54.0±0.8%), this was probably because ZnPP inhibited the endogenous CO production, 
and thus the cells utilized the exogenous NaHS to aid in the improvement of cell 
viability. This evidence illustrated that H2S and CO worked synergistically in this 
hypoxic model. As for the group when CORM-2 and PAG were administered 
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concurrently, the cell viability was 60.2±1.0%, the LDH level was 1.80±0.1 fold, with 
H2S concentration of 61.1±2.2μM. There was an increase in the cell viability as 
compared to CORM-2 (55.0±0.8%), probably because PAG effectively inhibited 
endogenous H2S production, thus with exogenous CO, the hypoxic cellular injury was 
abolished. This evidence might also show that H2S and CO worked hand in hand in this 
hypoxic model. 
Subsequently, when PAG and ZnPP were added concurrently, the cell viability 
was 37.0±0.8%, which corresponded to higher LDH level of 2.98±0.07 fold. The high 
degree of hypoxic cellular injury was correlated to a low H2S concentration of 
44.5±0.9μM. As for the group pretreated with PAG, the cell viability was only 
42.8±1.1% and the LDH level was 2.83±0.01 fold. This is similar to Zhu et al. (2007) 
whereby cell viability deteriorated significantly by PAG pretreatment (62.2±2.1%). The 
successful inhibition of H2S by PAG was also indicated by the detection of a low H2S 
concentration of 55.1±0.9μM. Finally for the last group where ZnPP was added only, 
with the inhibition of the endogenous CO production, the cell viability was 42.9±1.1%, 
LDH level was 2.71±0.08 fold. On the contrary, the H2S concentration was high with 
81.8±1.5μM. This might be that with the inhibition of endogenous CO, the cells increased 
its endogenous H2S content so as to attempt to eradicate the hypoxic cellular injury. 
4.3.2 H2S and CO work synergistically for 24 hours hypoxia treatment as depicted 
in H2S assay and CSE activity 
Furthermore, to investigate if the H2S assay results were credible, CSE activity 
was carried out. CSE activity signifies the activity of the gene responsible for H2S 
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production, thus it is an accurate method to determine if the H2S content was plausible. 
Firstly, the CSE activity in HC decreased from 98.3±0.6 (μmol/ml)/g to 72.7±0.6 
(μmol/ml)/g, which was related to the decrease in H2S content from 81.8±0.2μM to 
62.3±0.9μM.  
Next, the cells pretreated with NaHS only and CORM-2 only had CSE activity of 
77.0±0.15 (μmol/ml)/g and 71.3±0.01 (μmol/ml)/g respectively. Interestingly, when 
pretreated with both NaHS and CORM-2, the CSE activity amplified to a higher level of 
144±1.1 (μmol/ml)/g, a few folds higher than when NaHS or CORM-2 was added 
individually. The CSE activity of these groups tallied with the H2S concentration, 
whereby in the NaHS pretreated group (90.0±1.7μM), CORM-2 pretreated group 
(68.3±1.7μM) were several folds lower compared to when both NaHS and CORM-2 
(145±1.9μM) were added. For both CSE activity and H2S concentration data, they 
indicated that, when both NaHS and CORM-2 were added, there was a few folds 
improvement in the cellular injury compared to when NaHS or CORM-2 was 
administered individually. This meant that H2S and CO might work synergistically to 
eradicate hypoxic cellular injury, via the adjustment of CSE activity and exogenous H2S 
level. 
On the contrary, pretreatment with NaHS and ZnPP, yielded a CSE activity of 
59.6±2.9 (μmol/ml)/g, which was correlated with H2S concentration of 87.0±1.5μM. This 
decrease in CSE activity implied that ZnPP in fact inhibited its endogenous CO, but at the 
same time it also inhibited the CSE activity even though exogenous NaHS was added. 
This relationship implied that in fact H2S and CO may possibly interact with each other. 
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As for the group when CORM-2 and PAG were administered, the CSE activity was 
64.1±6.3 (μmol/ml)/g, with H2S concentration of 61.1±2.2μM. PAG had effectively 
suppressed the endogenous H2S depicted by the drop in H2S concentration, as compared 
to the HC (72.7±0.6 (μmol/ml)/g. 
As for the group pretreated with both PAG and ZnPP, with the successful 
repression of both endogenous H2S and CO, the CSE activity was reduced to 11.0±0.01 
(μmol/ml)/g. This was related to the drastic drop in H2S content of 44.5±0.9μM. 
Subsequently, with pretreatment of PAG, the CSE activity was 40.1±0.01 (μmol/ml)/g, 
depicting efficient inhibition of H2S with H2S content of 55.1±0.9μM. Lastly, in the ZnPP 
treated group, the CSE activity was 58.1±0.02 (μmol/ml)/g with a H2S concentration of 
81.8±1.5μM. Surprisingly, the H2S concentration was higher than HC (62.3±0.9μM). 
This might be that due to the suppression of endogenous CO by ZnPP, once the cellular 
stress was sensed by the cells, the cells thus increased its endogenous H2S content to 
abolish the hypoxic cellular injury. This implied that H2S and CO might work hand in 
hand to ameliorate the hypoxic cellular injury, probably via the altering CSE activity and 
exogenous H2S level. 
4.3.3 H2S and CO work synergistically for 24 hours hypoxia treatment as depicted 
in HO activity 
 From Morita et al. (1995), it was discovered that hypoxia increased the HO 
activity in rat aortic SMCs to a peak of 6.0 fold compared to control levels (713.72 ± 
23.74 pmol of bilirubin formed per mg of cell protein in 60 min). This was similar to our 
findings that in HC, the HO activity (93±0.02 (pmol bilirubin/mg/h)) was elevated 1.5 
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fold compared to NC (63±0.04 (pmol bilirubin/mg/h)). As for the relationship between 
HO activity and cell viability, the cell viability decreased from 94.5±0.6 %( NC) to 50± 
0.9% (HC). 
For the cells pretreated with NaHS, it had HO activity of 106±0.02 (pmol 
bilirubin/mg/h) despite in the absence of exogenous CO. This maybe in the presence of 
exogenous H2S, the HO activity was increased to enhance cell viability. As for the group 
treated with CORM-2, the HO activity was increased to 137±0.02 (pmol bilirubin/mg/h). 
Most prominently was when both NaHS and CORM-2 were administered, the HO 
activity elevated to a higher level of 173±0.02 (pmol bilirubin/mg/h), and several folds 
higher as compared to when pretreated with NaHS or CORM-2 individually. In this case, 
the HO activity was related to the cell viability. The evidence being that the cell viability 
was high when pretreated with NaHS (54.0±0.8%) and CORM-2 (55.0±0.8%) 
individually, showing that exogenous H2S and CO alleviated MI conditions. Similar to 
the HO activity data, the cell viability increased several folds when NaHS and CORM-2 
(91.2±1.6%) were added 
As for when NaHS and ZnPP were added, the HO activity was 126±0.04 (pmol 
bilirubin/mg/h) as compared to NaHS pretreatment group (106±0.02 (pmol 
bilirubin/mg/h)). The increase in HO activity might be that due to the inhibition the HO-1 
gene, thus the cells utilized the exogenous NaHS in attempting to remove the cellular 
damage. Next, for the group when CORM-2 and PAG were administered, the HO activity 
declined to 118±0.01 (pmol bilirubin/mg/h) as compared to the CORM-2 pretreatment 
group (137±0.02 (pmol bilirubin/mg/h)). This meant that PAG had effectively inhibited 
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endogenous H2S, thus the cells did not increase the HO activity. The HO activity was 
also correlated to the cell viability. When NaHS and ZnPP were administered, the cell 
viability increased to 60.3±1.0%. As for the group when CORM-2 and PAG were 
administered concurrently, the cell viability was similar at 60.2±1.0%, 
Next, when PAG and ZnPP were added concurrently, the HO activity declined to 
58±0.2 (pmol bilirubin/mg/h), signifying that ZnPP had effectively inhibited the HO-1 
gene and endogenous CO production. When the cells were pretreated with PAG only, the 
HO activity was surprisingly elevated to 125±1.0 (pmol bilirubin/mg/h). This meant that 
cells augmented the HO activity in an attempt to ameliorate the hypoxic damage. Lastly, 
when pretreated with ZnPP, with the inhibition of HO gene, the activity was 62±0.2 
(pmol bilirubin/mg/h). From the cell viability of PAG and ZnPP (37.0±0.8%) pretreated 
group and ZnPP (42.9±1.1%) pretreated group, it demonstrated that with a decrease in 
HO activity, the cell viability declined respectively. However with an exception of the 
decreased cell viability of PAG (42.8±1.1%) pretreated group, it might be due to the 
shorter time course (16hour) of implementation of the cell viability test whereby the cell 
viability test was performed before the cells were attempting to abolish the cellular 
damage via increasing HO activity.  
4.3.4 H2S and CO work synergistically for 24 hours hypoxia treatment as depicted 
in H2S assay and CSE mRNA level 
Next, RT-PCR was implemented to investigate whether the different treatment 
groups would up-regulate or down-regulate the expression of the CSE gene. Firstly, the 
 104
relative CSE mRNA level for the NC was defined as 100%. With hypoxic treatment, the 
HC CSE mRNA level decreased to 51.7±0.03%.  
For the NaHS pretreated group, the CSE mRNA level decreased to 30.9±0.2%. 
This implied that the exogenous H2S was sufficient for the mitigation of hypoxic cellular 
damage; hence the CSE mRNA level was low. As for the cells pretreated with CORM-2, 
the CSE mRNA level was 34.8±0.2%. When pretreated with both NaHS and CORM-2, 
the CSE mRNA level increased to 68.0±0.4 %, approximately double fold as compared to 
when NaHS or CORM-2 was added only. These data proved that H2S and CO might 
work synergistically to reduce the hypoxic cellular damage, found in MI conditions. 
Next, the CSE mRNA level for NaHS and ZnPP pretreatment group (47.2±0.3%) 
was higher than the NaHS pretreated group (30.9±0.2%). This was probably because 
ZnPP had effectively inhibited endogenous CO, thus the CSE mRNA level was increased 
to try to eliminate the hypoxic cellular damage. As for the CSE mRNA level for CORM-
2 and PAG pretreatment group (28.2±0.2%), it was lower than the CORM-2 pretreated 
group (34.8±0.2%). This indicated that PAG had in fact decreased the endogenous H2S 
successfully. 
Whereas when PAG and ZnPP were added simultaneously, the CSE mRNA level 
diminished to 17.4±0.1%, depicting successful repression of the CSE gene. As for the 
CSE mRNA level of PAG pretreatment group (33.8±0.2%), it indicated effective 
suppression of endogenous H2S. Finally, for the last group where ZnPP was added only, 
the CSE mRNA level was elevated drastically to 103±0.2%. This was because the cells 
detected the inhibition of endogenous CO, thus the CSE mRNA level was increased to 
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minimize the hypoxic cellular damage. This evidence showed that H2S and CO might 
have a relationship in reducing the hypoxic cellular damage. 
4.3.5 H2S and CO work synergistically for 24 hours hypoxia treatment as depicted 
in HO-1 mRNA level 
 After the investigation of the CSE mRNA levels for the different treatment 
groups, the HO-1 mRNA levels were also examined. Similarly, the relative HO-1 mRNA 
level for the NC was defined as 100%. In the HC, the HO-1 mRNA level decreased to 
21.7±0.14 %. This finding was supported by Morita et al. (1995), whereby the time 
course of hypoxia induced HO-1 mRNA to increase within 2 hours, then reached a 
maximum level by 15 hours, and decreased to basal levels during the subsequent 24 to 48 
hours. Furthermore, hypoxia inhibits HO-1 protein expression in rat cardiomyocytes 
(Ryter and Otterbein, 2004). Thus this explained the occurrence of the decrease of HO-1 
mRNA level in our HC experimental group. 
Next, the HO-1 mRNA levels in NaHS pretreated group and CORM-2 pretreated 
group were 50.7±0.36 % and 51.3±0.3 % respectively. The interesting discovery was in 
the NaHS and CORM-2 pretreatment group, whereby the HO-1 mRNA level increased to 
152±0.8 %, approximately triple as compared to when NaHS or CORM-2 was added 
individually. This was evident that H2S and CO might work together to lessen the 
hypoxic cellular damage as indicated by the increase in HO-1 gene expression. 
As for the HO-1 mRNA level of NaHS and ZnPP pretreated group (46.6±0.4 %), 
it was lower that the NaHS pretreated group (50.7±0.36 %), depicting successful 
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inhibition of endogenous CO production. Next, for the cells pretreated with CORM-2 and 
PAG (48.8±0.4 %), the mRNA level was lower than CORM-2 pretreated group 
(51.3±0.3), indicating that PAG could actually decrease the HO-1 mRNA level. 
 Next, when PAG and ZnPP were added, the HO-1 mRNA level reduced to 
17.0±0.2%, giving the connotation that ZnPP could effectively suppress HO-1 gene. 
However, in the PAG pretreated group, the HO-1 mRNA level was elevated to 
201±1.0%. This meant that the cells sensed the hypoxic cellular damage thus increased 
the HO-1 mRNA level to counter the damage. In the last group, with the successful 
suppression of endogenous CO via ZnPP, the HO-1 mRNA level declined to 43.8±0.2%. 
4.3.6 H2S and CO work synergistically for 24 hours hypoxia treatment as depicted 
in immunohistochemical staining 
 Much data were collected at the mRNA level, thus more was done to inspect at 
the protein level via immunohistochemical staining. Immunostaining is a method to 
depict the expression level of target genes. The principle involved was that it permitted 
the visualization of antigens via the sequential application of a specific primary antibody 
and secondary antibody to the antigen. Generally, no positive staining was detected for 
the negative controls of all treatment groups. As for the different treatment groups, 
positive staining was detected. For the NC, moderate positive staining of CSE was seen 
as opposed to the HC which had weak positive staining of CSE.  
 As for the NaHS treated group, strong signal of CSE was seen, indicative of the 
presence of CSE protein. Whereas for the cells treated with CORM-2, there was 
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moderate immunoreactivity. Interestingly, when pretreated with both NaHS and CORM-
2, it had the strongest CSE immunoreactivity. Hence, this might imply that H2S and CO 
might work jointly to attenuate the hypoxic cellular damage. 
Next for the NaHS and ZnPP treated group, there was strong signal of CSE, 
which was comparable to the NaHS pretreated only group.  As for the group pretreated 
with CORM-2 and PAG, relatively weak CSE immunoreactivity was detected as 
compared to the CORM-2 pretreated cells, meaning that PAG could suppress CSE. 
Then for PAG and ZnPP treated group, there was weakest CSE immunoreactivity, 
because of the effective inhibition of both endogenous H2S and CO. As for the last 2 
groups when pretreated with PAG only or ZnPP only, both had weak CSE 
immunoreactivity, showing the successful suppression of H2S and CO respectively. 
After the inspection of the CSE protein, HO-1 protein was the next protein target 
for immunohistochemical staining. Similarly, there was no positive staining of any 
protein product of targeted gene in the negative control of all treatment groups. As for the 
different treatment groups, positive staining was identified. For the NC, there was 
moderate HO-1 immunoreactivity as opposed to the HC which had weak positive staining 
of HO-1.  
Next, for the NaHS pretreated group, moderate HO-1 immunoreactivity was 
detected. For CORM-2 treated group, there was strong positive staining of HO-1. The 
most significant discovery was when pretreated with both NaHS and CORM-2; it had the 
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strongest HO-1 immunoreactivity. This meant that that H2S and CO might work in 
cooperation to alleviate the cellular damage inflicted by hypoxia. 
Next when NaHS and ZnPP were added, weaker HO-1 immunoreactivity 
indicated that ZnPP had effectively inhibited HO-1. As for the CORM-2 and PAG 
treatment group, because of the presence of CORM-2, strong positive staining of HO-1 
was identified. 
Then for PAG and ZnPP treated group, it had the weakest HO-1 
immunoreactivity because both CSE and HO-1 were suppressed.  As for the final 2 
groups pretreated with PAG only or ZnPP only, weak HO-1 immunoreactivity was 
observed. This was indicative of the successful inhibition H2S and CO respectively. 
From immunohistochemical staining of CSE and HO-1 proteins, we could only 
distinguish the extent of positive signal, whether it was strong signal or weak signal, from 
which protein expression levels were estimated. Unfortunately, no conclusive data could 
be drawn for protein expression from immunostaining. Hence, the future works included 
could be focused on improvement of the protein expression by performing western blot 
and ELISA to verify whether protein expression level is associated with mRNA 







In our previous study, we have established that H2S plays a critical role in 
cardioprotection in vitro and in vivo (Zhu et al., 2007). However, the exact mechanism of 
how H2S works is still unknown. Here in this project we proposed that probably H2S and 
CO work synergistically in the mitigation of hypoxic cellular damage. Undoubtedly from 
this project, we have ascertained that both H2S and CO do work together to ameliorate 
the hypoxic condition found in MI, simulated by the Modular Incubator Chamber (MIC-
101TM).  
The evidence from cell viability proved that in the NaHS and CORM-2 pretreated 
group, it was several folds higher than the NaHS pretreated or CORM-2 pretreated only 
groups. Furthermore, H2S assay results was closely related to the CSE activity whereby 
the highest H2S concentration and CSE activity were registered in the NaHS and CORM-
2 pretreated group, several folds higher compared to NaHS or CORM-2 only groups. For 
the HO-activity, when both NaHS and CORM-2 were administered, it was elevated by 
several folds as compared to when pretreated with NaHS or CORM-2 individually. 
Similarly, HO activity was related to cell viability.  
In addition, CSE and HO-1 mRNA levels pointed out that H2S and CO work 
synergistically, whereby the mRNA level in the NaHS and CORM-2 pretreatment group 
was several folds than when NaHS or CORM-2 was administered individually. Finally, 
the immunohistochemical staining results depicted the expression level of the regulation 
of target genes like CSE and HO-1.  
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The exact mechanism of how H2S and CO work together to reduce the hypoxic 
cellular damage in MI conditions is still not clearly defined. However, we have 
discovered that these 2 gasotransmitters improve cell viability induced by hypoxia, as 
proven by our research data. The mechanisms of how these 2 gasotransmitters work are 
probably through a feedback mechanism or involving other isoforms of CSE or HO-1. Of 
course, more experiments and future analysis needs to be implemented. In conclusion, 

















In this study, the relationship between H2S and CO was measured fairly directly. 
Thus the future direction would be to manipulate techniques to investigate the effects and 
molecular mechanisms of H2S and CO indirectly. ATP sensitive K+ channel responsible 
for H2S production could be examined (Zhao et al., 2001). It was found that 
vasorelaxation caused by H2S, was inhibited in a dose dependent manner by 
glibenclamide. On the other hand, pinacidil opened KATP channels, thus lowering blood 
pressure (Zhao et al., 2001). Thus we could use these drugs and investigate the 
interaction of H2S and CO in cells. We could administer pinacidil to the cells, with the 
opening of KATP channels; the levels of H2S should be elevated and thus CO levels could 
be examined. As for CO, it is known that it increases cGMP level, which induces the 
relaxation of the coronary artery. The direct downstream target of cGMP is cGMP-
dependent protein kinase (PKG), which in turn regulates Ca2+ gates and Ca2+ pumps on 
the endoplasmic reticulum and KCa channels on the plasma membrane (Wu and Wang, 
2005). Thus we could investigate cGMP changes in relation to role of CO in 
cardioprotection. As for the interaction between H2S and CO, both ATP sensitive K+ 
channels and cGMP levels need to be scrutinized; this may provide information for us 
about how H2S and CO work synergistically. Other additional techniques that we could 
focus are on improvement of the protein expression by performing western blot and 
ELISA to authenticate whether mRNA expression of the target genes is related to protein 
expression. 
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Although much literature has been published individually for H2S and CO in the 
area of IHD, not much research has been performed pertaining to the possibility of both 
of these 2 gasotransmitters in the treatment of MI.  Thus our future direction will be to 
investigate the detailed mechanism for both gasotransmitters responsible for the 
mitigation of cellular death in MI models. 
Lastly, another gaseous mediator NO could be investigated alongside with H2S 
and CO. For example, Geng et al. (2004) discovered that H2S was correlated with NO 
levels produced endogenously. Hence, we could explore the relationship of H2S, CO and 
NO altogether. It may provide more insight to the possible effects and relationship that 
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